{
  "meta": {
    "title": "00101_Mid_Day_Module_Obg-6",
    "url": "https://brainandscalpel.vercel.app/00101-mid-day-module-obg-6-33249104.html",
    "scrapedAt": "2025-11-29T18:12:57.722Z"
  },
  "questions": [
    {
      "id": 18383,
      "choices": [
        {
          "id": 73490,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenomyosis</span></p>"
        },
        {
          "id": 73491,
          "text": "<p><span style=\"font-size:12.0pt;\">Contraception</span></p>"
        },
        {
          "id": 73492,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometrial hyperplasia</span></p>"
        },
        {
          "id": 73493,
          "text": "<p><span style=\"font-size:12.0pt;\">Asymptomatic fibroid uterus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The LNG-IUS system as shown below can be used for all the following except?</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/screenshot-2024-01-01-131725.jpg\" alt=\"\" width=\"300\" height=\"157\"></span></p><p>&nbsp;</p><p>&nbsp;</p>",
      "unique_key": "Q7834374",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745719,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: D. Asymptomatic fibroid uterus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Explanation:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Mirena is a type of Levonorgestrel – Intrauterine System (LNG-IUS)</span></li><li><span style=\"font-size:12.0pt;\">It contains levonorgestrel – 52 mg in total with a release rate of 20μg/ day</span></li><li><span style=\"font-size:12.0pt;\">Effective life: 5 years</span></li><li><span style=\"font-size:12.0pt;\"><strong>Uses:&nbsp;</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Contraception</span></li><li><span style=\"font-size:12.0pt;\">Non contraceptive uses (Mnemonic: <strong>Mirena</strong> <strong>S</strong>a<strong>f</strong>ekeeps <strong>End</strong>angered <strong>A</strong>nimals)</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12.0pt;\"><strong>End</strong>ometriosis</span></li><li><span style=\"font-size:12.0pt;\"><strong>S</strong>ymptomatic fibroid (not distorting the cavity)</span></li><li><span style=\"font-size:12.0pt;\"><strong>End</strong>ometrial hyperplasia</span></li><li><span style=\"font-size:12.0pt;\"><strong>A</strong>denomyosis</span></li></ul></li></ul></li><li><span style=\"font-size:12.0pt;\">There is no indication for use of LNG-IUS in an asymptomatic fibroid</span></li><li><span style=\"font-size:12.0pt;\"><strong>Contraindications to Mirena:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Unexplained uterine or vaginal bleeding</span></li><li><span style=\"font-size:12.0pt;\">Post abortal sepsis</span></li><li><span style=\"font-size:12.0pt;\">Puerperal sepsis</span></li><li><span style=\"font-size:12.0pt;\">Endometrial cancer</span></li><li><span style=\"font-size:12.0pt;\">Cervical cancer</span></li><li><span style=\"font-size:12.0pt;\">Gestational trophoblastic neoplasia</span></li><li><span style=\"font-size:12.0pt;\">Current Pelvic inflammatory disease</span></li><li><span style=\"font-size:12.0pt;\">Genital Tuberculosis</span></li><li><span style=\"font-size:12.0pt;\">Large fibroid distorting the uterine cavity</span></li><li><span style=\"font-size:12.0pt;\">Mullerian anomalies distorting the uterine cavity</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Let's look at each option:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Adenomyosis</strong>: Adenomyosis is a condition where the inner lining of the uterus (endometrium) breaks through the muscle wall of the uterus. The LNG-IUS releases hormones that can thin the endometrial lining, reducing the symptoms of adenomyosis, such as heavy menstrual bleeding and pain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Contraception</strong>: One of the primary uses of LNG-IUS is contraception. It works by releasing levonorgestrel, a progestin, which thickens the cervical mucus to prevent sperm from reaching an egg, thins the lining of the uterus, and partially suppresses ovulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong> <strong>Endometrial Hyperplasia</strong>: LNG-IUS is used in the treatment of endometrial hyperplasia, a condition where the lining of the uterus becomes too thick. It is especially beneficial in cases without atypia, as it can reduce the proliferation of the endometrial cells, thereby reducing the risk of developing endometrial cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Asymptomatic Fibroid Uterus&nbsp;</strong>(Correct Answer): While LNG-IUS can help in managing symptoms of uterine fibroids such as heavy menstrual bleeding, but it does not have effect on the size reduction. hence its role is limited in asymptomatic fibroid. In asymptomatic fibroid, the goal is to reduce size of fibroid</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Mirena is a type of Levonorgestrel – Intrauterine System (LNG-IUS)</span></li><li><span style=\"font-size:12.0pt;\">It contains levonorgestrel – 52 mg in total with a release rate of 20μg/ day</span></li><li><span style=\"font-size:12.0pt;\">Effective life: 5 years</span></li><li><span style=\"font-size:12.0pt;\"><strong>Uses:&nbsp;</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Contraception</span></li><li><span style=\"font-size:12.0pt;\">Non contraceptive uses (Mnemonic: <strong>Mirena</strong> <strong>S</strong>a<strong>f</strong>ekeeps <strong>End</strong>angered <strong>A</strong>nimals)</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12.0pt;\"><strong>End</strong>ometriosis</span></li><li><span style=\"font-size:12.0pt;\"><strong>S</strong>ymptomatic fibroid (not distorting the cavity)</span></li><li><span style=\"font-size:12.0pt;\"><strong>End</strong>ometrial hyperplasia</span></li><li><span style=\"font-size:12.0pt;\"><strong>A</strong>denomyosis</span></li></ul></li></ul></li><li><span style=\"font-size:12.0pt;\">There is no indication for use of LNG-IUS in an asymptomatic fibroid</span></li><li><span style=\"font-size:12.0pt;\"><strong>Contraindications to Mirena:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Unexplained uterine or vaginal bleeding</span></li><li><span style=\"font-size:12.0pt;\">Post abortal sepsis</span></li><li><span style=\"font-size:12.0pt;\">Puerperal sepsis</span></li><li><span style=\"font-size:12.0pt;\">Endometrial cancer</span></li><li><span style=\"font-size:12.0pt;\">Cervical cancer</span></li><li><span style=\"font-size:12.0pt;\">Gestational trophoblastic neoplasia</span></li><li><span style=\"font-size:12.0pt;\">Current Pelvic inflammatory disease</span></li><li><span style=\"font-size:12.0pt;\">Genital Tuberculosis</span></li><li><span style=\"font-size:12.0pt;\">Large fibroid distorting the uterine cavity</span></li><li><span style=\"font-size:12.0pt;\">Mullerian anomalies distorting the uterine cavity</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 272, Shaw’s Textbook of Gynecology, 16<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 73493,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18384,
      "choices": [
        {
          "id": 73494,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Depot medroxyprogesterone acetate</span></span></span></p>"
        },
        {
          "id": 73495,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vaginal contraceptive ring</span></span></span></p>"
        },
        {
          "id": 73496,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Progestin implants</span></span></span></p>"
        },
        {
          "id": 73497,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ulipristal acetate</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 19y unmarried nulliparous girl comes to the OPD. She is sexually active and wants to know more about the contraceptive options available to her. All can be recommended to her except?</span></span></span></p>",
      "unique_key": "Q7464734",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745720,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: D. Ulipristal acetate</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Contraceptive of choice in adolescents is dual method i.e condom + any other form of contraception (Condom prevents against STI&rsquo;s)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Methods commonly used in adolescence:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Barrier (male condom, female condom)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hormonal contraception:</span></span></span>\r\n\t\t<ul style=\"list-style-type:square\">\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Combined OCPs</span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Extended cyclic pills </span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Progestin only pills</span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Transdermal patches</span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vaginal contraceptive ring (Nuva ring)</span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Injectable hormonal contraceptives</span></span></span>\r\n\t\t\t<ul style=\"list-style-type:disc\">\r\n\t\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">DMPA</span></span></span></li>\r\n\t\t\t</ul>\r\n\t\t\t</li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Progestin implants (Implanaon, Norplant)</span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Intra-Uterine Devices</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ulipristal acetate is a Selective Progesterone Receptor Modulator and is used as an emergency contraceptive.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Let us look at each option:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A: Depot Medroxyprogesterone Acetate (DMPA)</span></strong><span style=\"font-size:12.0pt\">: This is an injectable form of contraception that is administered every three months. It is a progestin-only method, making it suitable for women who may not be able to use estrogen-containing contraceptives. DMPA is highly effective and convenient for those who prefer not to take a daily pill.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong><span style=\"font-size:12.0pt\"> <strong>Vaginal Contraceptive Ring</strong>: The vaginal ring is a small, flexible ring that a woman inserts into her vagina. It releases estrogen and progestin, similar to combination oral contraceptives, but requires less frequent attention as it is typically changed monthly. It is a convenient and effective form of contraception.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C: Progestin Implants</span></strong><span style=\"font-size:12.0pt\">: These are small rods implanted under the skin of the arm that release a steady dose of progestin. They can provide long-term contraception for up to three to five years. The implant is a highly effective, low-maintenance option.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D: Ulipristal Acetate</span></strong><span style=\"font-size:12.0pt\"> (Correct Answer): Ulipristal acetate is used as an emergency contraceptive, not a regular method of contraception. It is intended for use after unprotected intercourse or contraceptive failure (like a broken condom) to prevent pregnancy. It&#39;s not designed for ongoing, regular use as a contraceptive method.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">When advising a sexually active young woman on contraceptive options, it is important to discuss a range of choices, including hormonal methods like depot medroxyprogesterone acetate injections, vaginal contraceptive rings, and progestin implants. Each of these offers long-term contraception with varying administration methods to suit different preferences. Ulipristal acetate, however, is an emergency contraceptive and is not suitable for regular contraceptive use.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 279, Shaw&rsquo;s Textbook of Gynecology, 16<sup>th</sup> edition</span></span></strong></p>",
      "correct_choice_id": 73497,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18385,
      "choices": [
        {
          "id": 73498,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">To reapply the patch with another adhesive</span></span></span></p>"
        },
        {
          "id": 73499,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">To apply a new patch</span></span></span></p>"
        },
        {
          "id": 73500,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">To apply a new patch and use a condom for 1 week</span></span></span></p>"
        },
        {
          "id": 73501,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">To remove the patch and use a condom till her next period</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 23y woman has been using the transdermal patch as a contraceptive method. She visits the OPD with the complaint that the patch was partially detached for more than a day. What will you advise her?</span></span></span></p>",
      "unique_key": "Q3113683",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745721,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: C. To apply a new patch and use a condom for 1 week</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">If the patch was detached for less than 24 h, the same patch can be reattached or a replaced with a new one. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">If a patch is partially or completely detached for more than one day (24 hours or more) <strong>OR </strong>if the woman is not sure how long the patch has been detached, she may not be protected from pregnancy. She should stop the current contraceptive cycle and start a new cycle immediately by applying a new patch. Back-up contraception, such as a condom, spermicide, or diaphragm, must be used for the first week of the new cycle.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong><span style=\"font-size:12.0pt\">In cases where the contraceptive patch has been detached for more than 24 hours, it is important to apply a new patch immediately and use a backup method of contraception, such as condoms, for the next 7 days. This ensures continuous contraceptive protection while accounting for any period during which the effectiveness of the patch may have been compromised.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><a href=\"https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021180s038lbl.pdf\" style=\"color:blue; text-decoration:underline\"><strong>https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021180s038lbl.pdf</strong></a><span style=\"color:blue\"><u><strong>, </strong></u></span><span style=\"color:blue\"><u><strong>Williams textbook of Gynecology 3<sup>rd</sup> edition page122</strong></u></span></span></span></span></p>",
      "correct_choice_id": 73500,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18386,
      "choices": [
        {
          "id": 73502,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Implanon</span></span></span></p>"
        },
        {
          "id": 73503,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Minipill</span></span></span></p>"
        },
        {
          "id": 73504,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">LNG-IUS</span></span></span></p>"
        },
        {
          "id": 73505,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nuva-ring</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">All the following can be given as contraceptives in a lactating mother except?</span></span></span></p>",
      "unique_key": "Q1867067",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745722,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: D. Nuva-ring</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In lactating women, Estrogen containing contraceptives are not preferred to be given as they reduce the quantity and quality of breast milk. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Progesterone containing contraceptives and non &ndash; hormonal contraceptives can be safely given. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amongst the given options</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Implanon &ndash; contains etonorgestrel</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Minipill &ndash; contains progesterone (Norethisterone OR Levonorgestrel OR Desogestrel)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">LNG-IUS contains Levonorgestrel</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nuva Ring &ndash; contains both Estrogen and Progesterone (ethinyl estradiol and etonorgestrel)</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"margin-left:96px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Let&#39;s review each option:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A: Implanon (Nexplanon)</span></strong><span style=\"font-size:12.0pt\">: Implanon is a progestin-only contraceptive implant that is inserted under the skin of the upper arm. It releases a small amount of hormone over time. Progestin-only methods are generally considered safe for use during lactation as they have minimal effect on milk production and are unlikely to harm the nursing infant.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.</span></strong><span style=\"font-size:12.0pt\"> <strong>Minipill</strong>: The minipill is a progestin-only oral contraceptive. Like Implanon, it is generally safe for use during breastfeeding. The progestin-only formulation is less likely to affect milk supply compared to combined oral contraceptives that contain both estrogen and progestin.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong><span style=\"font-size:12.0pt\"> <strong>LNG-IUS (Levonorgestrel-releasing Intrauterine System)</strong>: The LNG-IUS, like Mirena, releases levonorgestrel, a type of progestin, and is inserted into the uterus. It is considered safe for use in breastfeeding mothers as it has minimal systemic hormonal effects and primarily acts locally on the uterine lining.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D: NuvaRing</span></strong><span style=\"font-size:12.0pt\"> (Correct Answer): The NuvaRing is a combined hormonal contraceptive that contains both estrogen and progestin. Estrogen-containing contraceptives are typically not recommended for breastfeeding mothers, especially in the early postpartum period.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For lactating mothers (&lt; 6 months post-partum), estrogen containing contraceptives are contra-indicated. </span></span></span></p>\r\n\r\n<p style=\"margin-left:96px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Williams Textbook of Gynecology 3<sup>rd</sup> edition , page 106</span></strong></span></span></p>",
      "correct_choice_id": 73505,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18392,
      "choices": [
        {
          "id": 73526,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Stop breastfeeding</span></span></span></p>"
        },
        {
          "id": 73527,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Take the tablet at the same time everyday</span></span></span></p>"
        },
        {
          "id": 73528,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Use barrier contraception also</span></span></span></p>"
        },
        {
          "id": 73529,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It can be used as emergency contraception</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 20 y P2L2 who delivered 2 months back has decided to take progesterone only pill as a contraceptive. What important advice should be given?</span></span></span></p>",
      "unique_key": "Q2442964",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745723,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: B. Take the tablet at the same time everyday</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Progesterone only pills (POP) are also known as mini-pills</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">They can be started after delivery in lactating/ non lactating women or within the first 5 days (preferably 1<sup>st</sup> day) of the periods. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">POPs are safe in lactation. Combined Oral Contraceptive Pills (OCPs) containing both estrogen (E) and progesterone (P) reduce the quantity and quality of breast milk and thus are contraindicated in lactation</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mini pills are best taken at the same time everyday. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">If there is a dose delay of &gt; 3 h, a backup method should be used for 48h but for desogestrel (Cerazette) containing POPs, the safety margin is 12 hours</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">No other contraceptive is required with POP unless there has been a dose delay. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It cannot be used as an emergency contraception. High dose OCPs (E + P) can be used as emergency contraception.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Let us look at each option:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A: Stop Breastfeeding</span></strong><span style=\"font-size:12.0pt\">: This advice is not appropriate. The progesterone-only pill is actually a preferred choice for breastfeeding mothers because it does not affect milk supply as estrogen-containing contraceptives can. It is safe to use while breastfeeding.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong><span style=\"font-size:12.0pt\"> <strong>Take the Tablet at the Same Time Every Day</strong> (Correct Answer): This is crucial advice for a woman taking the progesterone-only pill. The effectiveness of the POP depends on consistent daily intake at the same time each day. The time window for taking the POP is narrower than for combined oral contraceptives; a delay of even a few hours can decrease its effectiveness and increase the risk of pregnancy.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C: Use Barrier Contraception Also</span></strong><span style=\"font-size:12.0pt\">: While using barrier methods in addition can provide extra protection against sexually transmitted infections (STIs), it is not a requirement for the effectiveness of the POP. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D: It Can be Used as Emergency Contraception</span></strong><span style=\"font-size:12.0pt\">: The regular progesterone-only pill is not intended for use as emergency contraception. There are specific emergency contraceptive pills available for that purpose. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:&nbsp;</span></strong><span style=\"font-size:12.0pt\">For a woman taking the progesterone-only contraceptive pill, it is essential to take the pill at the same time every day to maintain its contraceptive effectiveness. The POP is a suitable choice for breastfeeding mothers as it does not affect milk supply and is safe for the baby. It is not used as emergency contraception, and while barrier methods can be used alongside for added protection and STI prevention, they are not necessary for the effectiveness of the pill itself.</span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 403, DC Dutta&rsquo;s Textbook of Gynecology, 7<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 73527,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18423,
      "choices": [
        {
          "id": 73650,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Preventing ovulation by suppressing FSH and LH </span></span></span></p>"
        },
        {
          "id": 73651,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Destroying the ovum</span></span></span></p>"
        },
        {
          "id": 73652,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Helping prevent implantation by suppressing development of the endometrium</span></span></span></p>"
        },
        {
          "id": 73653,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hampering sperm transport by thickening cervical mucus </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The primary mechanism of action of the Combined Oral Contraceptives is:</span></span></span></p>",
      "unique_key": "Q7625053",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745724,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: A. Preventing ovulation by suppressing FSH and LH&nbsp; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The main action of combined oral contraceptives is:</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ovulation suppression: Most important</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other effects</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endometrial atrophy</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cervical mucus thickening</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Alteration of ovum transport</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Since the main mechanism of action is asked; the answer is Prevention of ovulation</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Let&#39;s explore each option:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Option A</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">. <strong>Preventing ovulation by suppressing FSH and LH</strong> (Correct Answer): COCs primarily prevent ovulation. They achieve this by suppressing the secretion of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland. Without the surge in LH, ovulation does not occur. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Option B</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">. <strong>Destroying the ovum</strong>: COCs do not work by destroying the ovum. They primarily prevent the ovum from being released from the ovary.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Option C</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">. <strong>Helping prevent implantation by suppressing development of the endometrium</strong>: While COCs do cause some thinning of the endometrium, making it less receptive to implantation, this is not their primary mechanism of action. It&#39;s more of a secondary effect that contributes to the contraceptive efficacy in case ovulation does occur.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Option D.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\"> <strong>Hampering sperm transport by thickening cervical mucus</strong>: This is another secondary mechanism of action of COCs. The progestin component in the COCs thickens the cervical mucus, making it more difficult for sperm to travel through the cervix and into the uterus. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">The primary mechanism of action of combined oral contraceptives is the suppression of ovulation through the inhibition of the hormones FSH and LH. Secondary mechanisms, such as alterations in the endometrial lining and thickening of cervical mucus, further enhance their contraceptive effectiveness. </span></span><span style=\"font-size:12.0pt\">Top of Form</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 398, DC Dutta&rsquo;s Textbook of Gynecology, 7<sup>th</sup> edition</span></span></strong></p>",
      "correct_choice_id": 73650,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18426,
      "choices": [
        {
          "id": 73662,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Once a week </span></span></span></p>"
        },
        {
          "id": 73663,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Twice a week</span></span></span></p>"
        },
        {
          "id": 73664,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Once a week for 12 weeks followed by twice a week from the 13th week onwards</span></span></span></p>"
        },
        {
          "id": 73665,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Twice a week for 12 weeks followed by once a week from the 13th week onwards</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dosage of Centchroman for contraception is?</span></span></span></p>",
      "unique_key": "Q8064948",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745725,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: D. Twice a week for 12 weeks followed by once a week from the 13th week onwards</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Centchroman is ormeloxifene </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is a selective estrogen receptor modulator (SERM)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Developed by the Central Drug Research Institute, Lucknow</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is a non &ndash; hormonal, synthetic contraceptive</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Low cost</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Initially marketed as Saheli and now as Chhaya by the Govt of India</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Contains 30 mg </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Recommended dose: 1 tablet twice weekly from the 1<sup>st</sup> day of menstruation for 3 months followed by once a week</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">99% effective</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Centchroman (Ormeloxifene) is administered as part of a specific dosing regimen for contraception, starting with twice a week for the first 12 weeks, followed by a maintenance dose of once a week from the 13th week onwards<span style=\"color:#374151\">.</span></span> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 278, Shaw&rsquo;s Textbook of Gynecology, 7<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 73665,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18433,
      "choices": [
        {
          "id": 73690,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cervical cancer</span></span></span></p>"
        },
        {
          "id": 73691,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Colorectal cancer</span></span></span></p>"
        },
        {
          "id": 73692,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endometrial cancer</span></span></span></p>"
        },
        {
          "id": 73693,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ovarian cancer</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Combined oral contraceptive pills are associated with a decreased risk of all the following cancers except?</span></span></span></p>",
      "unique_key": "Q3586180",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745726,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: A. Cervical cancer</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Oral contraceptives decrease the risk of 3 cancers</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endometrial</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ovarian</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Colorectal</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Oral contraceptives increase the risk of 2 cancers</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Breast</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cervical (no clear association but some studies have observed a slight increase in the incidence)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Slight increase in the risk of liver adenomas </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Let us look at each option separately:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cervical Cancer</span></strong> (Correct Answer): The use of COCs has been linked with an increased risk of cervical cancer. This risk appears to increase with the duration of COC use and declines after cessation of use. The increased risk is thought to be related to the role of human papillomavirus (HPV) in cervical carcinogenesis, with COCs possibly affecting the body&#39;s immune response to HPV or the progression of HPV infection to cervical cancer.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B.</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Colorectal Cancer</span></strong>: Several studies have shown a reduced risk of colorectal cancer in women who use COCs. The mechanism behind this protective effect is not fully understood .</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C.</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometrial Cancer</span></strong>: COCs have been consistently associated with a reduced risk of endometrial cancer. This protective effect is believed to be due to the progestin component of COCs, which opposes the proliferative effect of estrogen on the endometrium and reduces the risk of endometrial hyperplasia and subsequent malignancy.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D.</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ovarian Cancer</span></strong>: Use of COCs has also been linked to a decreased risk of ovarian cancer. The risk reduction appears to be substantial and increases with the duration of use. This protective effect is thought to be related to the suppression of ovulation that occurs with COC use, as each ovulation event is a potential opportunity for malignant transformation in the ovarian epithelium.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Oral contraceptives decrease the risk of 3 cancers</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endometrial</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ovarian</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Colorectal</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Oral contraceptives increase the risk of 2 cancers</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Breast</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cervical (no clear association but some studies have observed a slight increase in the incidence)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Slight increase in the risk of liver adenomas </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 401, DC Dutta&rsquo;s Textbook of Gynecology, 7<sup>th</sup> edition</span></span></strong></p>",
      "correct_choice_id": 73690,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18290,
      "choices": [
        {
          "id": 73118,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Less incidence of hemorrhage</span></span></span></span></p>"
        },
        {
          "id": 73119,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Higher success rate</span></span></span></span></p>"
        },
        {
          "id": 73120,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Non invasive</span></span></span></span></p>"
        },
        {
          "id": 73121,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Less incidence of PID</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 25-year-old G2P1L1 at 8 weeks pregnancy wants a medical termination of pregnancy for failure of contraception. She wants to know the advantages of medical abortion over surgical methods. All are true except?</span></span></span></p>",
      "unique_key": "Q2639743",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745727,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans: B.</span></span></strong> <strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Higher success rate</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Explanation:</span></span></strong> </span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Advantages of medical abortion:</span></span></span></span></p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Lesser incidence of haemorrhage, PID, perforation, long term sequelae like subfertility, cervical insufficiency and Asherman syndrome</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Non invasive</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">No anesthesia required</span></span></span></span></li>\r\n</ol>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Disadvantages of medical abortion:&nbsp;</span></span></span></span></p>\r\n\r\n<p style=\"margin-left:40px\"><em><span style=\"font-size:14px\">1. Success rate less than surgical abortion (95-99% with medical abortion; almost 100% with surgical evacuation)</span></em></p>\r\n\r\n<p style=\"margin-left:40px\"><em><span style=\"font-size:14px\">2. Takes about 2 weeks for completion (Surgical procedure is quicker and gets done in a 15-30 minutes.&nbsp;</span></em></p>\r\n\r\n<p style=\"margin-left:40px\">&nbsp;</p>\r\n\r\n<p><em><span style=\"font-size:14px\">Other Options:&nbsp;</span></em></p>\r\n\r\n<ul>\r\n\t<li><em><span style=\"font-size:14px\">Option A: Less incidence of hemorrhage is an advantage of medical MTP</span></em></li>\r\n\t<li>Option C: Non invasive: is an advantage of medical MTP</li>\r\n\t<li>Option D: Less incidence of PID: Is an advantage of medical MTP</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Advantages of medical abortion:</span></span></span></span></p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Lesser incidence of haemorrhage, PID, perforation, long term sequelae like subfertility, cervical insufficiency and Asherman syndrome</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Non invasive</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">No anesthesia required</span></span></span></span></li>\r\n</ol>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Disadvantages of medical abortion:&nbsp;</span></span></span></span></p>\r\n\r\n<p style=\"margin-left:40px\"><em><span style=\"font-size:14px\">1. Success rate less than surgical abortion (95-99% with medical abortion; almost 100% with surgical evacuation)</span></em></p>\r\n\r\n<p style=\"margin-left:40px\"><em><span style=\"font-size:14px\">2. Takes about 2 weeks for completion (Surgical procedure is quicker and gets done in a 15-30 minutes.&nbsp;</span></em></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ref: page no 361; William&rsquo;s Obstetrics 25<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 73119,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18482,
      "choices": [
        {
          "id": 73886,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Colposcopy</span></span></span></p>"
        },
        {
          "id": 73887,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Remove the LNG-IUS</span></span></span></p>"
        },
        {
          "id": 73888,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Reassure the patient </span></span></span></p>"
        },
        {
          "id": 73889,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ultrasound for endometrial thickness</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 38y woman opts for LNG-IUS for contraception. After 6 months she reports back to the OPD with complaints of periods of amenorrhea with irregular spotting. She had previous regular cycles and a pap smear done prior to insertion of the LNG-IUS was normal. What is the best next step in management?</span></span></span></p>",
      "unique_key": "Q6890006",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745728,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: C. Reassure the patient&nbsp; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">LNG-IUS is a 3<sup>rd</sup> generation Intrauterine device</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It contains levonorgestrel and mainly acts by causing endometrial atrophy</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A common side effect is amenorrhoea and irregular spotting for which only reassurance is required</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">80% of women are amenorrhoeic by the end of 1 year</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Effective life: 5 years</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Failure rate: 0.1%</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">**Since pap smear was normal 6 months back, there is no indication for a colposcopy</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">** There is no indication to remove the LNG-IUS</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">**USG for endometrial thickness is not required as this is a known side effect of LNG-IUS</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Let us look at each option:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A.</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Colposcopy</span></strong>: This is a diagnostic procedure to examine the cervix for signs of disease, typically indicated if there are abnormal findings on a Pap smear. Since the patient had a normal Pap smear prior to the insertion of the LNG-IUS and her current symptoms are related to menstrual changes, colposcopy is not indicated in this case.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Remove the LNG-IUS</span></strong>: Removal of the LNG-IUS is generally reserved for situations where there are serious complications or persistent, unacceptable side effects. Irregular spotting and periods of amenorrhea are common and expected side effects of the LNG-IUS, especially in the first 6 to 12 months of use.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C.</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reassure the patient</span></strong> (Correct Answer): The most appropriate step in this scenario is to reassure the patient. The LNG-IUS releases levonorgestrel locally within the uterus, which can lead to thinning of the endometrial lining and result in changes to menstrual bleeding patterns, including lighter periods, irregular spotting, or amenorrhea. These changes are considered normal side effects of the LNG-IUS and often stabilize within the first year of use.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ultrasound for Endometrial Thickness</span></strong>: While ultrasound can be used to assess endometrial thickness, it is not typically indicated in this scenario unless there are other symptoms or clinical findings suggestive of endometrial pathology. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Irregular spotting and episodes of amenorrhea are common side effects of the Levonorgestrel-releasing intrauterine system (LNG-IUS) and usually stabilize within the first year of use. These effects are due to the local action of levonorgestrel on the endometrium. Patients experiencing these changes without other concerning symptoms can generally be reassured about the normalcy of these side effects.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 403, DC Dutta&rsquo;s Textbook of Gynecology, 7<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 73888,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18490,
      "choices": [
        {
          "id": 73918,
          "text": "<p><span style=\"font-size:12.0pt;\">Take both the missed tablets immediately, use additional contraceptive method for 7 days and advise emergency contraception</span></p>"
        },
        {
          "id": 73919,
          "text": "<p><span style=\"font-size:12.0pt;\">Take the last missed pill as soon as possible, use additional contraceptive for 7 days and omit the 7-day pill free period</span></p>"
        },
        {
          "id": 73920,
          "text": "<p><span style=\"font-size:12.0pt;\">Use emergency contraception and continue taking the remaining pills</span></p>"
        },
        {
          "id": 73921,
          "text": "<p><span style=\"font-size:12.0pt;\">Use emergency contraception and discard the remaining pills.</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">An 18y unmarried girl has been using Mala N as a contraceptive method. She comes to the family planning OPD on Day 24 of her period with the complaint that she has missed taking the pills on Day 22 and 23. She is extremely worried and anxious about the risk of conceiving as she had unprotected intercourse on Day 6. What will you advise her?</span></p>",
      "unique_key": "Q5512456",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745729,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: B. Take the last missed pill as soon as possible, use additional contraceptive for 7 days and omit the 7- day pill free period</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Explanation: Missing a pill increases the risk of pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Management of Missed Pill</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/02/screenshot-2024-01-02-150415.jpg\" alt=\"\" width=\"900\" height=\"659\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">** In this question, she has missed 2 pills in the 3<sup>rd</sup> week. Hence, she should take the last missed pill, use additional contraception and omit the pill free interval and start the next pack immediately after finishing the current pack.</span></p><p>&nbsp;</p><p><span style=\"color:#374151;font-size:12pt;\">Here's an explanation of the options:</span></p><p>&nbsp;</p><p><span style=\"color:#374151;font-size:12pt;\"><strong>Option A.</strong> <strong>Take both the missed tablets immediately, use an additional contraceptive method for 7 days, and advise emergency contraception</strong>: Taking both missed pills at once is not necessary and may increase the risk of side effects like nausea. Emergency contraception is not typically recommended in this scenario.</span></p><p>&nbsp;</p><p><span style=\"color:#374151;font-size:12pt;\"><strong>Option B</strong>. <strong>Take the last missed pill as soon as possible, use additional contraceptive for 7 days, and omit the 7-day pill-free period</strong> (Correct Answer): This is the recommended action for missing two consecutive pills in the third week of the cycle. She should take the most recently missed pill as soon as possible (even if it means taking two pills in one day) and then continue with the rest of the pack as normal, without taking a 7-day pill-free break. Using an additional </span><span style=\"font-size:12pt;\">contraceptive method, like condoms, for the next 7 days is important to ensure protection against pregnancy.</span></p><p>&nbsp;</p><p><span style=\"color:#374151;font-size:12pt;\"><strong>Option&nbsp;</strong></span><span style=\"font-size:12pt;\"><strong>C.</strong> <strong>Use emergency contraception and continue taking the remaining pills</strong>: Emergency contraception is usually not necessary if the missed pills are managed correctly, as described in option B. However, if there is significant concern about pregnancy risk or if the guidance for missed pills is not followed correctly, emergency contraception could be considered.</span></p><p>&nbsp;</p><p><span style=\"color:#374151;font-size:12pt;\"><strong>Option&nbsp;</strong></span><span style=\"font-size:12pt;\"><strong>D</strong>. <strong>Use emergency contraception and discard the remaining pills</strong>: Discarding the remaining pills is not advised. Instead, she should continue taking her pills as per the guidance for missed pills to maintain contraceptive protection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In the case of missing two consecutive combined oral contraceptive pills in the third week, the recommended approach is to take the last missed pill as soon as possible (ignoring the earlier missed pill), continue taking the remaining pills as scheduled, use an additional contraceptive method for the next 7 days, and skip the 7-day pill-free break. This approach helps maintain contraceptive protection and reduces the risk of pregnancy due to the missed pills. Emergency contraception is typically not necessary if these steps are followed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Faculty of Sexual and Reproductive Health Care Clinical Effectiveness Unit. CEU Statement (May 2011). Missed Pill Recommendations. 2011. </strong></span><a href=\"http://www.fsrh.org/pdfs/CEUStatementMissedPills.pdf\"><span style=\"font-size:12.0pt;\"><strong><u>http://www.fsrh.org/pdfs/CEUStatementMissedPills.pdf</u></strong></span></a><span style=\"font-size:12.0pt;\"><strong> (Accessed 19th August 2021)</strong></span></p>",
      "correct_choice_id": 73919,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18496,
      "choices": [
        {
          "id": 73942,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Combined oral contraceptive pills</span></span></span></p>"
        },
        {
          "id": 73943,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Centchroman</span></span></span></p>"
        },
        {
          "id": 73944,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">LNG-IUS</span></span></span></p>"
        },
        {
          "id": 73945,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Depot medroxyprogesterone acetate</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 24y woman comes to the gyn OPD seeking contraceptive advice. She is married and has a 4-year-old son. She is a known epileptic and is on lamotrigine. Which of the following contraceptives will require you to increase the dose of lamotrigine?</span></span></span></p>",
      "unique_key": "Q7457965",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745730,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: A. Combined oral contraceptive pills</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Combined oral contraceptive pills induce lamotrigene metabolism, thereby reducing plasma levels. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Women taking OCPs and on lamotrigene are advised to increase the dose of lamotrigine</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Let us look at each option:</span></span></span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A.</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Combined Oral Contraceptive Pills (Correct Answer)</span></strong>: Combined oral contraceptives (COCs) contain both estrogen and a progestin. Estrogen can increase the metabolism of lamotrigine, potentially lowering its levels in the blood and reducing its effectiveness. Therefore, if a woman on lamotrigine chooses to use COCs, her lamotrigine dosage may need to be adjusted to maintain seizure control.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Centchroman</span></strong>: This is a non-steroidal, non-hormonal contraceptive, known also as Ormeloxifene. It works as a selective estrogen receptor modulator and is unlikely to interact with lamotrigine. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LNG-IUS (Levonorgestrel-releasing Intrauterine System)</span></strong>: The LNG-IUS, such as Mirena, releases levonorgestrel directly into the uterus. The systemic absorption of levonorgestrel is minimal compared to oral contraceptives, and it is unlikely to significantly interact with lamotrigine. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Depot Medroxyprogesterone Acetate (DMPA)</span></strong>: DMPA is a progestin-only injectable contraceptive. Progestin-only methods are less likely to interact with lamotrigine compared to estrogen-containing methods. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">In a woman with epilepsy on lamotrigine therapy, the use of combined oral contraceptive pills may necessitate an adjustment in the lamotrigine dosage due to estrogen-induced increased metabolism of lamotrigine. Non-hormonal methods like Centchroman or progestin-only methods like the LNG-IUS and DMPA are less likely to interact with lamotrigine and are generally safer options in terms of drug interactions for women with epilepsy.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp; Epilepsy in Pregnancy Green-top Guideline No. 68 June 2016 ( RCOG )</span></span></strong></p>",
      "correct_choice_id": 73942,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18500,
      "choices": [
        {
          "id": 73958,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Take the missed pill as soon as possible and continue the remaining packet</span></span></span></p>"
        },
        {
          "id": 73959,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Take the missed pill as soon as possible and offer her emergency contraception also</span></span></span></p>"
        },
        {
          "id": 73960,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Take the missed pill as soon as possible and use additional contraception for 7 days</span></span></span></p>"
        },
        {
          "id": 73961,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Take the missed pill as soon as possible, use emergency contraception and discard the remaining packet</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 23y woman is taking Oral Contraceptive Pills regularly since the past 2 years. She presents to the family planning OPD on Day 8 of her menstrual cycle with the complaint that she has missed taking the pill on Day 7. What will you advise her?</span></span></span></p>",
      "unique_key": "Q2147067",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745731,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: A. Take the missed pill as soon as possible and continue the remaining packet</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Management of Missed Pill</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/02/screenshot-2024-01-02-152519.jpg\" style=\"height:642px; width:900px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#374151\">Let&#39;s look &nbsp;at all the &nbsp;options:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#374151\">Option A.</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#374151\"> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Take the missed pill as soon as possible and continue the remaining packet</span></strong> (Correct Answer): This is the recommended advice for a single missed pill. She should take the missed pill as soon as she remembers, even if this means taking two pills in one day. The risk of pregnancy is low with only one missed pill, especially if she has been taking the pills regularly for a long time. She can then continue taking the rest of the pills in the packet as usual.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#374151\">Option B.</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#374151\"> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Take the missed pill as soon as possible and offer her emergency contraception also</span></strong>: Emergency contraception is not necessary for a single missed pill, provided she resumes taking her pills as advised. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#374151\">Option C.</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#374151\"> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Take the missed pill as soon as possible and use additional contraception for 7 days</span></strong>: Using additional contraception for 7 days is the standard advice if two or more pills are missed consecutively, especially in the first week of the pack. However, for a single missed pill, this extra precaution is not typically necessary.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#374151\">Option D</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#374151\">. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Take the missed pill as soon as possible, use emergency contraception and discard the remaining packet</span></strong>: This advice is excessive for a single missed pill. There is no need to discard the remaining pills or use emergency contraception.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When a woman misses a single combined oral contraceptive pill, the best course of action is to take the missed pill as soon as possible and then continue taking the rest of the pills in the packet as scheduled. Additional measures such as emergency contraception or extended use of barrier methods are not necessary for a single missed pill.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Faculty of Sexual and Reproductive Health Care Clinical Effectiveness Unit. CEU Statement (May 2011). Missed Pill Recommendations. 2011. </span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><a href=\"http://www.fsrh.org/pdfs/CEUStatementMissedPills.pdf\" style=\"color:blue; text-decoration:underline\"><strong><span style=\"font-size:12.0pt\">http://www.fsrh.org/pdfs/CEUStatementMissedPills.pdf</span></strong></a></span></span><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (Accessed 19th August 2021)</span></span></strong></p>",
      "correct_choice_id": 73958,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18510,
      "choices": [
        {
          "id": 73998,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CuT380A</span></span></span></p>"
        },
        {
          "id": 73999,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Depot medroxyprogesterone acetate</span></span></span></p>"
        },
        {
          "id": 74000,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Norplant</span></span></span></p>"
        },
        {
          "id": 74001,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Triphasic pill</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">All are examples of Long-Acting Reversible Contraception (LARC) except?</span></span></span></p>",
      "unique_key": "Q1494757",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745732,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: D. Triphasic pill</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Long-Acting Reversible Contraception (LARC) methods are defined as methods requiring administration less than once cycle/ month</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">LARC methods include</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Intrauterine devices</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Progesterone implants</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Injectable contraceptives</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">They require a single act of motivation for long term use eliminating adherence and user dependence</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at each option :</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#374151\">Option&nbsp;</span></span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CuT380A</span></strong>: This is a Copper T 380A intrauterine device (IUD), a type of LARC. It can provide up to 10 years of contraception. The device is placed inside the uterus and works by releasing copper, which is toxic to sperm.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#374151\">Option&nbsp;</span></span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Depot Medroxyprogesterone Acetate (DMPA)</span></strong>: DMPA is an injectable form of contraception, commonly known as Depo-Provera. It is administered every three months and is considered a LARC because of its prolonged duration of action and the minimal requirement for user adherence.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#374151\">Option&nbsp;</span></span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Norplant</span></strong>: Norplant, which is no longer available in many countries but has similar successors like Jadelle, consists of implantable rods that release a progestin. This method is a LARC, providing effective contraception for several years.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#374151\">Option&nbsp;</span></span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Triphasic Pill</span></strong> (Correct Answer): The triphasic pill is a form of combined oral contraceptive pill (COC). It is not a LARC; it requires daily administration and adherence by the user. The &quot;triphasic&quot; refers to the varying levels of hormones in the pills over the course of the cycle to mimic the natural menstrual cycle more closely.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Long-Acting Reversible Contraception (LARC) methods include devices and formulations like the CuT380A IUD, Depo-Provera injections, and implantable progestin rods (e.g., Norplant, Jadelle), which provide effective contraception for an extended period with minimal need for user action. In contrast, the triphasic pill, a type of combined oral contraceptive, requires daily administration and does not fall under the category of LARC</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no. 697, JB Sharma&rsquo;s Textbook of Obstetrics, 1<sup>st</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 74001,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18518,
      "choices": [
        {
          "id": 74030,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2 doses of OCPs (Each dose containing 100 mcg of EE) 12h apart</span></span></span></p>"
        },
        {
          "id": 74031,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2 doses of OCPs (Each dose containing 100 mcg of EE) 24h apart</span></span></span></p>"
        },
        {
          "id": 74032,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2 doses of OCPs (Each dose containing 50 mcg of EE) 12h apart</span></span></span></p>"
        },
        {
          "id": 74033,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2 doses of OCPs (Each dose containing 50 mcg of EE) 24h apart</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A couple approaches the gyn OPD as they are worried about an act of unprotected intercourse and the chances of pregnancy. They have heard about Yuzpe regime. What does this regime contain?</span></span></span></p>",
      "unique_key": "Q3115968",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745733,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: A. 2 doses of OCPs (Each dose containing 100 mcg of EE) 12h apart</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Yuzpe regime is 2 doses of OCPs (Each dose containing 100 mcg of EE) 12h apart; it can be given within 72h of an act of unprotected intercourse; not commonly used because of the vomiting associated with such high dose. </span></span></span></li>\r\n</ul>\r\n\r\n<p><em><strong>Educational Objective:&nbsp;</strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;emergency contraceptives available</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/02/screenshot-2024-01-02-160419.jpg\" style=\"height:481px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thus, option A.) 2 doses of OCPs (Each dose containing 100 mcg of EE) 12h apart is correct.</span></strong><strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The Yuzpe regimen involves taking two doses of oral contraceptive pills (OCPs), with each dose containing a high amount of ethinyl estradiol (EE) and a progestin, 12 hours apart. This method can be used within 72 hours (3 days) after unprotected intercourse to reduce the risk of pregnancy. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: Page no 243, Berek and Novak&rsquo;s Gynecology 15<sup>th</sup> edition</span></span></span></strong></p>",
      "correct_choice_id": 74030,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18525,
      "choices": [
        {
          "id": 74058,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">With full or near full breast-feeding, 70% of women remain amenorrheic through 6 months.</span></span></span></span></p>"
        },
        {
          "id": 74059,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">With partial feeding or no breast feeding, a contraceptive method should begin during the 3<sup>rd</sup> postpartum week.&nbsp;</span></span></span></span></p>"
        },
        {
          "id": 74060,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">The progestin only minipill does not affect lactation.</span></span></span></span></p>"
        },
        {
          "id": 74061,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">The vaginal ring can be used effectively in breast feeding mothers as absorption of estrogen is minimal and does not affect lactation.&nbsp;</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">All are true regarding postpartum contraception except:</span></span></span></p>",
      "unique_key": "Q2977648",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745734,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans: D. The vaginal ring can be used effectively in breast feeding mothers as absorption of estrogen is minimal and does not affect lactation.&nbsp;</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Explanation: </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The use of vaginal estrogen preparation is discouraged because absorption of estrogen can lead to inhibition of milk production.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at each option:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">With full or near full breast-feeding, 70% of women remain amenorrheic through 6 months</span></strong>: This is true. Lactational amenorrhea, is a common and natural form of contraception in the initial months postpartum. However, it&#39;s important to note that its effectiveness as a contraceptive method varies and should be considered in the context of exclusive breastfeeding and frequency of nursing.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">With partial feeding or no breast feeding, a contraceptive method should begin during the 3rd postpartum week</span></strong>: This is generally correct. For women who are not fully breastfeeding, fertility can return earlier, and it&#39;s advisable to start a contraceptive method by the third postpartum week to prevent unintended pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The progestin-only minipill does not affect lactation</span></strong>: True. Progestin-only contraceptives, like the minipill, are preferred during breastfeeding as they do not affect milk supply. These are safe to use in the postpartum period, including for women who are breastfeeding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The vaginal ring can be used effectively in breastfeeding mothers as absorption of estrogen is minimal and does not affect lactation</span></strong> (Incorrect Statement): This statement is not accurate. The vaginal ring typically contains both estrogen and progestin. Estrogen-containing contraceptives, including the vaginal ring, can potentially reduce breast milk supply and are generally not recommended for breastfeeding mothers, especially in the early postpartum period. While the systemic absorption may be lower than oral methods, the potential impact on lactation is still a concern.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In postpartum contraception, it&#39;s important to choose methods that are safe and effective for the mother, especially if she is breastfeeding. Progestin-only methods like the minipill are preferred during lactation as they do not affect milk supply. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: page no 878, Speroff&rsquo;s Clinical Gynecological Endocrinology and Infertility</span></span></span></strong></p>",
      "correct_choice_id": 74061,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18544,
      "choices": [
        {
          "id": 74134,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Hysteroscopy</span></span></span></span></p>"
        },
        {
          "id": 74135,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">No need of removal </span></span></span></span></p>"
        },
        {
          "id": 74136,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">IUCD hook</span></span></span></span></p>"
        },
        {
          "id": 74137,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Laparoscopy</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 28-year-old P1L1 had a Cu T inserted 2 years back. She comes for a checkup as she cant feel the threads. On examination Cu T threads are not seen. USG shows Cu T partly in abdominal cavity. Method of removal is?</span></span></span></span></p>",
      "unique_key": "Q6583823",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745735,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans: D. Laparoscopy</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Copper can cause inflammatory reaction and can cause intestinal obstruction. Therefore, it needs removal.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">When CuT is embedded within uterine cavity, hysteroscopic removal is the method of choice. It is preferred over IUCD hook as it is removed under direct visualization. But initial removal can be attempted in the OPD with an IUCD hook. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">When IUCD enters the abdominal cavity (partly or completely), laparoscopy is the preferred modality for retrieval. Sometimes due to dense adhesions around Cu T, a laparotomy may be required to remove it.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/02/screenshot-2024-01-02-180804.jpg\" style=\"height:372px; width:1000px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the above flowchart, please note that initially an ultrasound is done to see if the IUCD is in the uterine cavity or not. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">If it is not seen in the uterine cavity, then to confirm it is in the abdomen, an Xray (with a sound in the uterus) is done. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let&#39;s examine each option:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hysteroscopy</span></strong>: This is a procedure where a hysteroscope&nbsp; is inserted into the uterus through the cervix. It&#39;s used for diagnosing and treating intrauterine conditions. However, if the Cu T is in the abdominal cavity, hysteroscopy would not be appropriate or effective for removal.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">No need for removal</span></strong>: Leaving an IUD in the abdominal cavity is not advisable. It can lead to complications such as adhesions, perforation of other organs, or chronic pain. Therefore, removal is typically recommended.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IUCD Hook</span></strong>: An IUCD hook is used for retrieving IUD threads when they are within the cervical canal or the uterine cavity but not visible at the external os. Since the Cu T is in the abdominal cavity in this scenario, an IUCD hook would not be helpful.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laparoscopy</span></strong> (Correct Answer): Laparoscopy is a surgical procedure that uses a small incision and a camera to look inside the abdominal cavity. It&#39;s the most appropriate method for retrieving an IUD that has migrated into the abdominal cavity. This approach is minimally invasive and allows for the safe removal of the IUD.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When an IUD is dislodged from the uterus and located in the abdominal cavity, laparoscopic surgery is the preferred method for removal. This minimally invasive procedure allows for direct visualization and retrieval of the IUD, minimizing the risk of injury to abdominal and pelvic organs</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 484 DC Duttas textbook of gynecology, 6<sup>th</sup> edition</span></span></strong></p>",
      "correct_choice_id": 74137,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18546,
      "choices": [
        {
          "id": 74142,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Start next cycle of tablets immediately</span></span></span></span></p>"
        },
        {
          "id": 74143,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Start next cycle from next day</span></span></span></span></p>"
        },
        {
          "id": 74144,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Urine pregnancy test</span></span></span></span></p>"
        },
        {
          "id": 74145,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Wait for another 1 weeks for period</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Seema, a 32-year mother of 2 children, has been on Mala N for contraception. After the end of the first strip. there was no withdrawal bleeding. It has now been 7 days since the last tablet and she visits you. &nbsp;What should be done? </span></span></span></p>",
      "unique_key": "Q7282214",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745736,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans: C. Urine pregnancy test</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Explanation:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The first thing that needs to be ruled out is pregnancy. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hence UPT needs to be done.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">IF UPT is negative, she can start a new packet of OCPs, </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let&#39;s explore the options:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start next cycle of tablets immediately</span></strong>: While it&#39;s generally recommended to start the next pack of pills after the usual pill-free interval (or placebo pill week), doing so without addressing the absence of withdrawal bleeding could potentially overlook an early pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start next cycle from next day</span></strong>: Similar to option A, this does not address the underlying concern of potential pregnancy. It&#39;s important to rule out pregnancy before continuing with the next cycle of contraceptive pills.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urine Pregnancy Test (Correct Answer)</span></strong>: The absence of withdrawal bleeding at the end of a contraceptive pill cycle can be a sign of pregnancy, especially if the pills were not taken consistently or correctly. A urine pregnancy test (UPT) is a simple and effective way to rule out or confirm pregnancy before proceeding with further contraceptive use.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wait for another 1 week for period</span></strong>: While waiting could be an option, it might delay the identification of a potential pregnancy. Given that the patient is already at the end of her pill-free interval, it&#39;s more proactive to perform a pregnancy test to promptly address any potential pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In cases where a woman on combined oral contraceptive pills does not experience withdrawal bleeding, a pregnancy test should be performed to rule out the possibility of pregnancy, especially if there is any chance of inconsistent pill use. This is a critical step before starting a new pack of contraceptive pills. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 488, DC Duttas textbook of gynecology, 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 74144,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18984,
      "choices": [
        {
          "id": 75896,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Diabetes</span></span></p>"
        },
        {
          "id": 75897,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Multiparity</span></span></p>"
        },
        {
          "id": 75898,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Obesity</span></span></p>"
        },
        {
          "id": 75899,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Tamoxifen therapy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 50-year-old woman is diagnosed to have endometrial carcinoma on biopsy. She wishes to understand the high-risk factors for development of endometrial cancer. Which of the following is NOT a risk factor for development of endometrial carcinoma:</span></span></p>",
      "unique_key": "Q9829136",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745737,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Multiparity </span></strong></span></span></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/picture1_orutUsD.jpg\" style=\"height:647px; width:850px\" /></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Unopposed Estrogen therapy is seen in scenarios like PCOS, estrogen secretinf tumors like granulosa cell tumor and HRT with only estrogen</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:&nbsp;</span></span></strong></em></span></p>\r\n\r\n<p><span style=\"font-size:16px\"><em><strong><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Risk Factors for endometrial cancer include</span></span></strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\"><em><strong><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nulliparity</span></span></strong></em></span></li>\r\n\t<li><span style=\"font-size:16px\"><em><strong><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Early menarche and late menopause</span></span></strong></em></span></li>\r\n\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><em>Obesity</em></strong></span></span></li>\r\n\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><em>DM</em></strong></span></span></li>\r\n\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><em>Tamoxifen</em></strong></span></span></li>\r\n\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><em>Atypical Endometrial hyperplasia</em></strong></span></span></li>\r\n\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><em>Unopposed estrogen exposure&nbsp;</em></strong></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><em>PCOS</em></strong></span></span></li>\r\n\t\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><em>Granulosa cell ovarian tumor</em></strong></span></span></li>\r\n\t\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><em>HRT with only estrogen</em></strong></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><em>Genetic syndromes like Lynch syndrome (HNPCC) and Cowden syndrome</em></strong></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Berek &amp; Novak, 16 ed, page 2362</span></strong></span></span></p>",
      "correct_choice_id": 75897,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18986,
      "choices": [
        {
          "id": 75904,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Karman canulla</span></span></span></p>"
        },
        {
          "id": 75905,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Manual vacuum aspiration cannula</span></span></span></p>"
        },
        {
          "id": 75906,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pipelle endometrial aspiration cannula</span></span></span></p>"
        },
        {
          "id": 75907,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uterine sound </span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Identify the instrument given below:</span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/picture2.jpg\" style=\"height:273px; width:300px\" /></span></span></p>",
      "unique_key": "Q2240885",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745738,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Pipelle endometrial aspiration cannula</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">This is an office endometrial aspiration cannula available as many names like pipelle and the vibra aspirator</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">It is used to procure an endometrial aspirate as an OPD procedure as the cannula is so thin, it does not usually require cervical dilatation</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">This procedure is done in women with Abnormal Uterine Bleeding (AUB)</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">The other ways to obtain an endometrial sample for HPE is by</span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Hysteroecopic guided endometrial biopsy (Gold standard)</span></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Dilatation and curettage&nbsp;</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Other Options:</span></span></strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><strong>Option A: Karmans cannula:</strong> These are disposable plastic cannulas which are color coded dependng on their diameter and appear as shown below. They are used as aspiration cannulas which are attached to an manual vacuum aspirator and are used to aspirate products of conception.&nbsp;</span></li>\r\n</ul>\r\n\r\n<p><img alt=\"Karman Cannula, Karman Cannula with Universal Adoptor, Karman Cannula  without Universal Adopter\" src=\"https://www.mediplusindia.com/wp-content/uploads/2017/10/mi1.jpg\" /></p>\r\n\r\n<ul>\r\n\t<li><strong>Option B: Manual Vacuum Aspirator. </strong>This is attached to the Karman cannula and the vauum created is used in suction evacuation to aspirate products of conception</li>\r\n</ul>\r\n\r\n<p><img alt=\"White MVA Syringe, For Hospital And Laboratory\" src=\"https://5.imimg.com/data5/XU/RN/MY-2413456/mva-syringe.jpg\" /></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><strong>Option D: Uterine Sound: </strong>This is a slightly curved metal instrument used to measure the length of the uterine cavity in procedures like a D&amp;C or during insertion of an intra-uterine device</span></li>\r\n</ul>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image-20231217215354-1.png\" style=\"height:192px; width:204px\" /></p>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>An endometrial biopsy can be taken by</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Hysteroscopy guided endometrial biopsy (Gold standard)</strong></em></span></li>\r\n\t<li><span style=\"font-size:14px\"><em><strong>Dilatation and curettage</strong></em></span></li>\r\n\t<li><span style=\"font-size:14px\"><strong><em>Office endometrial aspiration in the OPD&nbsp;</em></strong></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ref :&nbsp; </strong><a href=\"https://www.semanticscholar.org/paper/Frequency-of-Positive-Endometrial-Pipelle-Biopsies-Zaman-Jabeen/30747f41d85e5bbb4783e846377d979c77102785\" style=\"color:#0563c1; text-decoration:underline\"><strong>https://www.semanticscholar.org/paper/Frequency-of-Positive-Endometrial-Pipelle-Biopsies-Zaman-Jabeen/30747f41d85e5bbb4783e846377d979c77102785</strong></a></span></span></p>",
      "correct_choice_id": 75906,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18989,
      "choices": [
        {
          "id": 75916,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometrial Carcinoma</span></span></span></p>"
        },
        {
          "id": 75917,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometrial hyperplasia</span></span></span></p>"
        },
        {
          "id": 75918,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Molar pregnancy</span></span></span></p>"
        },
        {
          "id": 75919,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Retained product of conception</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman visits OPD with heavy menstrual bleeding. Her USG is shown below Histopathology shows dilated cystic glands with increased gland: stroma ratio. The probable diagnosis is:</span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/picture6.jpg\" style=\"height:231px; width:350px\" /></span></span></p>",
      "unique_key": "Q8846957",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745739,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Endometrial hyperplasia</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Endometrial&nbsp;hyperplasia is a condition where there is endometrial thickening. It can be simple pr complex and with or without atypia. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Simple hyperplasia is characterized by dilated or cystic glands with round to slightly irregular shapes, an increased glandular-to-stromal ratio without glandular crowding</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Complex hyperplasia has architecturally complex (budding and infolding) crowded glands, with less intervering stroma</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Atypical hyperplasia refers to cytologic atypia and is a high risk for endometrial carcinoma</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Other Options</span></span></span></span></strong></em></p>\r\n\r\n<ol>\r\n\t<li><strong><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:14px\"><span dir=\"ltr\" lang=\"EN-IN\"><span style=\"color:black\">Option A: Endometrial cancer:</span></span></span></span></strong><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:14px\"><span dir=\"ltr\" lang=\"EN-IN\"><span style=\"color:black\"> In this the HPE will show features of carcinoma including&nbsp; c</span></span>ellular / nuclear enlargement, nuclear rounding with large nucleoli, loss of polarity and cytoplasmic eosinophilia</span></span></li>\r\n\t<li><strong><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:14px\">Option C: Molar Pregnancy: </span></span></strong><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:14px\">The USG image will show snowstorm appearance and the HPE will show, trophoblastic hyperplasia and villous edema</span></span></li>\r\n\t<li><strong><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:14px\">Option D: </span></span></strong><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:14px\">Retained products of conception: This will appear as trophoblastic tissue on microscopy</span></span></li>\r\n</ol>\r\n\r\n<p><em><span style=\"font-size:14px\"><strong>Educational Objective:&nbsp;</strong></span></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Endometrial&nbsp;hyperplasia is a condition where there is endometrial thickening. It can be simple pr complex and with or without atypia. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Simple hyperplasia is characterized by dilated or cystic glands with round to slightly irregular shapes, an increased glandular-to-stromal ratio without glandular crowding</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Complex hyperplasia has architecturally complex (budding and infolding) crowded glands, with less intervering stroma</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Atypical hyperplasia refers to cytologic atypia and is a high risk for endometrial carcinoma</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: berek &amp; novak, 16 ed, page 2364</span></strong></span></span></p>",
      "correct_choice_id": 75917,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18991,
      "choices": [
        {
          "id": 75924,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CA 125</span></span></span></p>"
        },
        {
          "id": 75925,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometrial aspiration biopsy</span></span></span></p>"
        },
        {
          "id": 75926,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pap smear</span></span></span></p>"
        },
        {
          "id": 75927,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prepare for hysterectomy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">55-year-old post-menopausal woman presents to OPD with post-menopausal bleeding. Her USG shows endometrial thickness of 7mm. Next step in management is:</span></span></p>",
      "unique_key": "Q7713994",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745740,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Endometrial aspiration biopsy</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#1c1d1e\">After physical and pelvic examination, the first test to evaluate for signs of endometrial cancer is transvaginal ultrasound</span></span></span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#1c1d1e\">If the endometrial thickness in a post menopausal woman is </span></span>&ge; 5mm, an endometrial biopsy should be done.&nbsp;</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">An endometrial biopsy can be obtained by</span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Office endomtrial aspiration</span></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Dilatation and curettage</span></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Hysteroscopy and biopsy (Gold standard)</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li>\r\n\t<ul>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Other Options:&nbsp;</span></span></strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><strong>Option A:</strong>&nbsp;CA 125: This is a marker for epithelial ovarian cancer</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><strong>Option C:</strong> Pap smear: This is a screening test for cervical cancer. In the queston it is already mentioned that the endometrium is thickened so taking a pap smear will not be the net best step</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><strong>Option D:</strong> Prepare for a hysterectomy: Am endometrial biopsy is required an only if there is endometrial hyperplasia with atypia or if ther eis endometrial carcinoma, should a hysterectomy be done</span></span></li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Educational Objective:&nbsp;</span></span></strong></em></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#1c1d1e\">After physical and pelvic examination, the first test to evaluate for signs of endometrial cancer is transvaginal ultrasound</span></span></span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#1c1d1e\">If the endometrial thickness in a post menopausal woman is </span></span>&ge; 5mm, an endometrial biopsy should be done.&nbsp;</span></span></li>\r\n\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">An endometrial biopsy can be obtained by</span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Office endomtrial aspiration</span></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Dilatation and curettage</span></span></li>\r\n\t\t<li><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Hysteroscopy and biopsy (Gold standard)</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: figo cancer report, 2021</span></strong></span></span></p>",
      "correct_choice_id": 75925,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18996,
      "choices": [
        {
          "id": 75944,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Type I endometrial cancer: due to unopposed estrogen</span></span></p>"
        },
        {
          "id": 75945,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Type I endometrial cancer: due to unopposed progesterone</span></span></p>"
        },
        {
          "id": 75946,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Type II endometrial cancer: due to unopposed estrogen</span></span></p>"
        },
        {
          "id": 75947,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Type II endometrial cancer: due to unopposed progesterone</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In relation to endometrial cancer which of the following is CORRECT:</span></span></p>",
      "unique_key": "Q1966014",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745741,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Type I endometrial cancer: due to unopposed estrogen</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometrial cancer is of 2 types: Type 1 (endometroid) and type 2 (non endometroid)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type I endometrial cancers occur in women with history of exposure to unopposed estrogen. Type II endometrial carcinoma are estrogen independent tumors. </span></span></span></li>\r\n</ul>\r\n\r\n<p><img alt=\"Different characteristics of type 1 and type 2 endometrial cancer |  Download Table\" src=\"https://www.researchgate.net/publication/268335090/figure/tbl2/AS:686347681542145@1540649447437/Different-characteristics-of-type-1-and-type-2-endometrial-cancer.png\" /></p>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<p><img alt=\"Different characteristics of type 1 and type 2 endometrial cancer |  Download Table\" src=\"https://www.researchgate.net/publication/268335090/figure/tbl2/AS:686347681542145@1540649447437/Different-characteristics-of-type-1-and-type-2-endometrial-cancer.png\" /></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Berek &amp; novak, 16 edition, page 2362</span></strong></span></span></p>",
      "correct_choice_id": 75944,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19228,
      "choices": [
        {
          "id": 76872,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"color:black\">Cervarix</span></span></span></p>"
        },
        {
          "id": 76873,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"color:black\">Cervavac</span></span></span></p>"
        },
        {
          "id": 76874,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"color:black\">Gardasil</span></span></span></p>"
        },
        {
          "id": 76875,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"color:black\">Gardasil 9</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A P4L4, 43-year-old woman presents to OPD with post coital bleeding. On cervical biopsy, she is found to have CIN III. You counsel her about her treatment and also guide her for preventive strategy for her 2 daughters (17 years, 12-year-old) with HPV vaccine.&nbsp;</span></span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Which of the following is the indigenous cervical cancer vaccine soon to be available in India by serum institute of India: </span></span></span></span></p>",
      "unique_key": "Q9820651",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745742,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. B. Cervavac</span></span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: </span></span></strong><a href=\"https://isccp.in/cervavac-the-new-buzz/\" style=\"color:#0563c1; text-decoration:underline\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">https://isccp.in/cervavac-the-new-buzz/</span></span></strong></a></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The National Cancer Institute of the US National Institute of Health (NIH) reports that three vaccines are currently being offered in numerous nations all over the world to prevent infection with the disease-causing HPV. These include Cervarix, Gardasil, and Gardasil 9.</span></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The vaccines Cervarix is bivalent, Gardasil 9 is nonavalent, and Gardasil is quadrivalent. This translates to four, nine, and two HPV strains in Gardasil, Gardasil 9, and Cervarix, respectively.</span></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">HPV types 6, 11, 16, and 18 are prevented by Gardasil, while HPV types 16 and 18 are prevented by Cervarix.<br />\r\nInfection with HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58 is prevented with Gardasil 9.</span></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Cervavac: Tetravalent or quadrivalent L1 virus-like particles (VLPs) of serotypes 6, 11, 16, and 18 are part of the serum institute of India (SII)&rsquo;s HPV vaccination.&nbsp;</span></span></span></span></span></p>",
      "correct_choice_id": 76873,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19239,
      "choices": [
        {
          "id": 76916,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:black\">HPV testing should be used as a method of cancer cervix screening after 25 years of age </span></span></span></p>"
        },
        {
          "id": 76917,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:black\">HPV should only be used in adjunct with either Pap&rsquo;s smear or liquid based cytology</span></span></span></p>"
        },
        {
          "id": 76918,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:black\">An interval of 5-10 years is recommended when using HPV as primary screening </span></span></span></p>"
        },
        {
          "id": 76919,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:black\">Women with previous 2 HPV screen negative can stop screening after the age of 60 years</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Human Papilloma Virus (HPV) is the causative agent in majority of cervical cancers. Which of the following is TRUE in relation to HPV testing as per WHO guidelines?</span></span></span></p>",
      "unique_key": "Q7407835",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745743,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans: C: Interval of 5-10 years is recommended when using HPV as primary screening </span></span></strong></span></span></p>\r\n\r\n<p><strong>Explanation:&nbsp;</strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">WHO recommends starting regular cervical cancer screening at the <strong>age of 30 years </strong>among the general population of women.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">WHO recommends using <strong>HPV DNA detection as the primary screening test </strong>rather than VIA or cytology in screening and treatment approaches among both the general population of women and women living with HIV</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">WHO suggests a <strong>regular screening interval of every 5 to 10 years when using HPV DNA </strong>detection as the primary screening test among the general population of women</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">After the age of 50 years</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">, WHO suggests screening is stopped after two consecutive negative screening results consistent with the recommended regular screening intervals among both the general population of women and women living with HIV</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Other options:&nbsp;</span></span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:black\">Option A: HPV testing should be used as a method of cancer cervix screening after 25 years of age: This is incorrect as screening with HPV should start at age 30&nbsp;</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:black\">Option B:&nbsp;HPV should only be used in adjunct with either Pap&rsquo;s smear or liquid based cytology: This is also incorrect. As per WHO, HPV alone is the preferred screening test</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:black\">Option D:&nbsp;Women with previous 2 HPV screen negative can stop screening after the age of 60 years: This is also incorrect.&nbsp;</span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">After the age of 50 years</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">, WHO suggests screening is stopped after two consecutive negative screening results consistent with the recommended regular screening intervals among both the general population of women and women living with HIV</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><em><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:&nbsp;</span></span></span></span></strong></em></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">WHO recommends starting regular cervical cancer screening at the <strong>age of 30 years </strong>among the general population of women.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">WHO recommends using <strong>HPV DNA detection as the primary screening test </strong>rather than VIA or cytology in screening and treatment approaches among both the general population of women and women living with HIV</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">WHO suggests a <strong>regular screening interval of every 5 to 10 years when using HPV DNA </strong>detection as the primary screening test among the general population of women</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">After the age of 50 years</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">, WHO suggests screening is stopped after two consecutive negative screening results consistent with the recommended regular screening intervals among both the general population of women and women living with HIV</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition, 2021</span></span></strong></span></span></p>",
      "correct_choice_id": 76918,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19244,
      "choices": [
        {
          "id": 76936,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Cervical biopsy</span></span></span></p>"
        },
        {
          "id": 76937,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Liquid based cytology</span></span></span></p>"
        },
        {
          "id": 76938,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Visual inspection with acetic acid</span></span></span></p>"
        },
        {
          "id": 76939,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Visual inspection with lugol&rsquo;s iodine</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A woman visited hospital in rural area for &ldquo;see and treat&rdquo; cervical cancer screening. Which method is being used for screening in the given image:</span></span></span></p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/16/1_akrJ1Ac.jpg\" style=\"height:254px; width:338px\" /></span></span></span></p>",
      "unique_key": "Q7985815",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745744,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">And C: Visual inspection with acetic acid</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Visual inspection with acetic acid (VIA): </span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A speculum is introduced and acetic acid is applied to the cervix. Those women with acetowhite lesions are considered abnormal. </span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Done with 3% acetic acid.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: DC dutta textbook of gynaecology 6<sup>th</sup> edition, page 324, fig: 22.6A</span></span></strong></span></span></p>",
      "correct_choice_id": 76938,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19230,
      "choices": [
        {
          "id": 76880,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Ayers spatula for Pap smear </span></span></span></p>"
        },
        {
          "id": 76881,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Cytobrush for Liquid based cytology </span></span></span></p>"
        },
        {
          "id": 76882,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Pipelle&rsquo;s for endometrial aspiration</span></span></span></p>"
        },
        {
          "id": 76883,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Vaginal swab for chlamydia screening </span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Identify the procedure done with the instrument given: </span></span></span></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/17/whatsapp-image-2023-06-12-at-190188_nDAGw7I.jpg\" style=\"height:302px; width:400px\" /></p>",
      "unique_key": "Q2420326",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745745,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans: B: Cytobrush for Liquid based cytology</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Berek and novak 16<sup>th</sup> edition, page number 925</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The ubiquitous use of liquid-based medium to collect the cytologic sample and preserve the collected cervical cells significantly decreased specimen sampling and preparation errors.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">With this technique, liquid samples areprocessed to provide a uniform, thin layer of cervical cells without debris on a glass slide. The cell sample is collected with an endocervical brush used in combination with a plastic spatula or with a plastic broom. The sample is rinsed in a vial containing liquid alcohol-based preservative. With this technique, 80% to 90% of the cells are transferred to the liquid media, as compared with the 10% to&nbsp;</span></span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">20% transferred to the glass slide with conventional cytologic testing. Use of liquid-based media eliminates air drying. The cells are retrieved from the vial by passing the liquid through a filter, which traps the larger epithelial cells, separating them from the small blood and inflammatory cells. This process yields a thin layer of diagnostic cells properly preserved and more easily interpreted by the cytologist. This technique reduces by 70% to 90% the rate of unsatisfactory samples encountered with conventional cytologic testing</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: DC dutta textbook of gynaecology page no: 627</span></span></strong></span></span></p>",
      "correct_choice_id": 76881,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19237,
      "choices": [
        {
          "id": 76908,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Colposcopy</span></span></span></p>"
        },
        {
          "id": 76909,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">HPV testing</span></span></span></p>"
        },
        {
          "id": 76910,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Liquid based Cytology</span></span></span></p>"
        },
        {
          "id": 76911,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Pap&rsquo;s smear</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 38-year-old female, P3L3 comes to Gynaecology OPD for routine checkup, and you offer her cervical cancer screening. Which is the preferred primary modality for cervical cancer screening</span></span></span></p>",
      "unique_key": "Q5459328",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745746,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans: B : HPV testing </span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Recent update in WHO,2021</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition, 2021</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">WHO recommends using HPV DNA detection as the primary screening test rather than VIA or cytology in screening and treatment approaches among both the general population of women and women living with HIV. </span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Existing programmes with quality-assured cytology as the primary screening test should be continued until HPV DNA testing is operational; existing programmes using VIA as the primary screening should transition rapidly because of the inherent challenges with quality assurance. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Methods for cervical cancer screening: </span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/16/5_0BGImRb.jpg\" style=\"height:389px; width:1197px\" /></span></span></strong></span></span></p>",
      "correct_choice_id": 76909,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19246,
      "choices": [
        {
          "id": 76944,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Colposcopy</span></span></span></p>"
        },
        {
          "id": 76945,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Hysteroscopy</span></span></span></p>"
        },
        {
          "id": 76946,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Laparoscopy</span></span></span></p>"
        },
        {
          "id": 76947,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"color:black\">Vaginoscopy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 35-year-old woman underwent Pap smear screening which showed HSIL/ CIN III. The woman was advised further the following test. Identify the procedure: </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/16/3_vUJG0SF.jpg\" style=\"height:227px; width:418px\" /></span></span></span></p>",
      "unique_key": "Q7604785",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745747,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans: A. Colposcopy</span></span></strong></span></span></p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref DC DUTTA 6<sup>th</sup> edition, page 116, fig: 9.20</span></span></span></strong></p>",
      "correct_choice_id": 76944,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19323,
      "choices": [
        {
          "id": 77252,
          "text": "<p><span style=\"background-color:transparent;font-size:16px;\">Ultrasonography&nbsp;</span></p>"
        },
        {
          "id": 77253,
          "text": "<p><span style=\"color:#46403d;font-size:12pt;\">CT scan</span></p>"
        },
        {
          "id": 77254,
          "text": "<p><span style=\"color:#46403d;font-size:12.0pt;\">MRI</span></p>"
        },
        {
          "id": 77255,
          "text": "<p><span style=\"color:#46403d;font-size:12pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 55 years old P5L5 presented to OPD with postcoital bleeding and vaginal discharge. On examination, there is a 3 x 3cm growth involving the entire cervix. The growth does not seem to extend to the vagina and the parametrium is free. Which of the following investigations can be used for staging of cancer cervix:</span></p>",
      "unique_key": "Q8081033",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745748,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. All of the above</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:white;font-size:12pt;\">In 2018, the FIGO (Federation of International Gynecologists and Obstetricians) Gynecologic Oncology Committee revised the staging to allow the option of clinical, radiological, or pathological findings, as available, to assign the stage. FIGO 2018 staging permits the use of any of the imaging modalities according to available resources,<strong> i.e. ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET)</strong>, to provide additional information on tumor size, nodal status, and local or systemic spread.</span></p><p>&nbsp;</p><p><span style=\"background-color:white;font-size:12pt;\">MRI is the best method of radiologic assessment of primary tumors greater than 10&nbsp;mm.</span></p><p>&nbsp;</p><p><span style=\"background-color:white;font-size:12pt;\">T<strong>he stage is allocated after all imaging and pathology reports are available</strong>. It is not to be altered later, for example at recurrence.</span></p><p>&nbsp;</p><p><span style=\"background-color:white;font-size:12pt;\">Educational Objective:</span></p><p>&nbsp;</p><ul><li><p style=\"text-align:justify;\">Cervical cancer is primarily a clinical staging but F<span style=\"background-color:white;font-size:12pt;\">IGO 2018 staging permits the use of any of the imaging modalities according to available resources,<strong> i.e. ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET)</strong>, to provide additional information on tumor size, nodal status, and local or systemic spread.</span></p></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref&nbsp; : FIGO cancer report 2021</strong></span></p>",
      "correct_choice_id": 77255,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19328,
      "choices": [
        {
          "id": 77272,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage IB1</span></span></span></p>"
        },
        {
          "id": 77273,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage IB2</span></span></span></p>"
        },
        {
          "id": 77274,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage IB3</span></span></span></p>"
        },
        {
          "id": 77275,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage IIA1</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 57 year old woman presents to OPD with complaint of discharge per vagina. There is a 3*3 cm visible growth on the cervix. Vagina and parametrium are uninvolved. The stage of the disease is: </span></span></p>",
      "unique_key": "Q7496682",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745749,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Stage IB2</span></strong></span></span></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/17/whatsapp-image-2023-06-12-at-1901123.jpg\" style=\"height:1770px; width:1000px\" /></p>\r\n\r\n<ul>\r\n\t<li><strong>In this patient, the cancer is limited to the cervix and between 2 cm to 4 cm so this is 1B2</strong></li>\r\n</ul>\r\n\r\n<p><strong>Educational Objective:</strong></p>\r\n\r\n<p><strong>Staging of cervical cancr is essential to learn as given in the table above</strong></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref :&nbsp; FIGO cancer report 2021</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>",
      "correct_choice_id": 77273,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19330,
      "choices": [
        {
          "id": 77280,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Allis tissue holding forcep</span></span></p>"
        },
        {
          "id": 77281,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Babcock forceps</span></span></p>"
        },
        {
          "id": 77282,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Cervical punch biopsy forcep</span></span></p>"
        },
        {
          "id": 77283,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Pipelle&rsquo;s endometrial biopsy forcep</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:#1a1a1a\">Identify the instrument: </span></span></span></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/17/whatsapp-image-2023-06-12-at-1901124.jpg\" style=\"height:346px; width:200px\" /></p>",
      "unique_key": "Q4366747",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745750,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Cervical punch biopsy forceps</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li>This is a cervical punch biopsy forceps</li>\r\n\t<li>It is used to take a biopsy from a cervical growth or suspicious area on the cervix</li>\r\n\t<li>The biopsy is taken form the periphery of the cervical growth (Never from the center)</li>\r\n</ul>\r\n\r\n<p><strong>Other options:&nbsp;</strong></p>\r\n\r\n<ul>\r\n\t<li>Allis Foceps: It is used to hold tough structures&nbsp;</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li>Babcock Forceps: It is an atraumatic forceps and is used to hold delicate structures like the fallopian tube</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li>Endometrial aspiration cannula: It is a thin cannula which is introduced through the cervix to take an endometrial sample. It does&nbsp;</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><strong>Educational Objective:</strong></span></p>\r\n\r\n<ul>\r\n\t<li>Any growth on the cervix should be biopsied using a punch biopsy forceps</li>\r\n</ul>\r\n\r\n<p><strong>Ref: Page no 605, DC Dutta&#39;s Textbook of Gynecology, 6th edition</strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>",
      "correct_choice_id": 77282,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19028,
      "choices": [
        {
          "id": 76072,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Endometrial Biopsy</span></span></span></span></span></p>"
        },
        {
          "id": 76073,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">LNG-IUD</span></span></span></span></span></p>"
        },
        {
          "id": 76074,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Myomectomy</span></span></span></span></span></p>"
        },
        {
          "id": 76075,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Hysterectomy</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">A 45-year lady presents with heavy menstrual bleeding for 3 months. On examination, she does not appear to be pale. Her BP is 150/90mmHg. An abdominal and pelvic exam is normal. A transvaginal scan shows a 2 cm Intramural fibroid and an endometrial thickness of 15mm. both the ovaries appear normal &nbsp;What is the next best step?</span></span></span></span></p>",
      "unique_key": "Q1082991",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745751,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Ans. A. Endometrial Biopsy</span></span></span></strong></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Explanation:</span></span></span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">At 45y, heavy bleeding during periods could be because of endometrial hyperplasia or malignancy. </span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">It&nbsp;is important to rule out precancerous lesions and cancerous lesions at this age. </span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">A small 2 cm fibroid is unlikely to be the cause of her symptoms but her increased endometrial thickness on the ultrasound (15 mm is a thick endometrium for her age) could be alikely cause.&nbsp;</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Th&nbsp;is thickened endometrium&nbsp;warrants an endometrial biopsy to tule out endometrial hyperplasia and cancer</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Educational Objective:</span></span></span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Fibroids and endometrial hyperplasia/ malignancy usually coexist as both are hyperestrogenic states</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Women in the peri-menopausal age group with fibroids with heavy menstrual bleeding should be evaluated for endometrial hyperplasia and cancer</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: Page no 946, William&rsquo;s Gynecology 3<sup>rd</sup> &nbsp;edition</span></span></strong></span></span></p>",
      "correct_choice_id": 76072,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19036,
      "choices": [
        {
          "id": 76104,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Endometrial ulceration</span></span></span></span></span></p>"
        },
        {
          "id": 76105,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Dysfunctional uterine contractility</span></span></span></span></span></p>"
        },
        {
          "id": 76106,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Increased endometrial surface area</span></span></span></span></span></p>"
        },
        {
          "id": 76107,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Increased uterine vascularity</span></span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">A 23-year with heavy menstrual bleeding is diagnosed to have fibroids. She is curious to know why fibroids cause heavy bleeding. Which of the following is not a cause of heavy bleeding in fibroids?</span></span></span></span></p>",
      "unique_key": "Q7025446",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745752,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Endometrial ulceration</span></strong></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fibroids cause heavy menstrual bleeding because of several reasons including</span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased endometrial surface area</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased vascularity</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dysfunctional uterine contractility</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Associated endometrial hyperplasia and PID</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:&nbsp;</span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fibroids cause heavy menstrual bleeding because of several reasons including</span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased endometrial surface area</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased vascularity</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dysfunctional uterine contractility</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Associated endometrial hyperplasia and PID</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"margin-left:96px\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: Page no 527, DC Dutta&rsquo;s Textbook of Gynecology 7<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 76104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19040,
      "choices": [
        {
          "id": 76120,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Improve anemia, pre-operatively</span></span></span></span></span></p>"
        },
        {
          "id": 76121,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Perimenopausal women</span></span></span></p>"
        },
        {
          "id": 76122,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#333333\">Shrink the size of the fibroid pre-operatively</span></span></span></span></span></p>"
        },
        {
          "id": 76123,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Small submucosal fibroid in an infertile woman</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Which is not an indication for medical management of fibroid uterus?</span></span></span></span></p>",
      "unique_key": "Q4263378",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745753,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Small submucosal fibroid in an infertile woman</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The indications of medical management in fibroid uterus is</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Patients not desirous of fertility but wanting uterine preservation</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Small symptomatic fibroids</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Improving anemia </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Peri-menopausal</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pre-op to shrink the size of the fibroid</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><em><strong>In an infertile woman, any submucosal fibroid, even if small has to be removed</strong></em></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></span></span></strong></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Remember if a woman is infertile; remove </span></span></span></p>\r\n\r\n<ul style=\"margin-left:40px\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Submucosal fibroids</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Intramural fibroids</span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&gt; 5 cm</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Distorting the endometrial cavity</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: Page no 527, DC Dutta&rsquo;s Textbook of Gynecology 7<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 76123,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19019,
      "choices": [
        {
          "id": 76036,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Laparoscopic myomectomy</span></span></span></p>"
        },
        {
          "id": 76037,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hysteroscopic myomectomy</span></span></span></p>"
        },
        {
          "id": 76038,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Reassurance</span></span></span></p>"
        },
        {
          "id": 76039,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">GnRH agonists</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 27-year woman who is anxious to conceive visits the OPD with her husband. They have been trying to conceive for 2 years. She has regular periods with heavy flow. There is associated dysmenorrhea. A transvaginal scan shows a submucosal fibroid of about 2 cm in size. What is the best management option?</span></span></p>",
      "unique_key": "Q8969315",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745754,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Hysteroscopic myomectomy</span></strong></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation: </span></span></span></strong></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This patient is infertile and has a submucosal fibroid. The fibroid has to be removed. Type 0 and 1 submucosal fibroids are best removed hysteroscopically</span></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options</span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option A:</strong> Laparoscopic myomectomy: Is indicated usually in intramural and subserosal fibroids</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option B:</strong> Reassurance: Whenever an infertile patient has a submucosal fibroid or a large intra-mural fibroid, it has to be removed.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option C:</strong> GnRH agonist: Could have been tried if the patient did not have infertility.&nbsp;</span></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Indications of myomectomy in infertility are:</span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Submucous fibroids</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Large intramural fibroids distorting the cavity.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Intramural fibroids &gt; 5cm</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Submucosal fibroids are best removed hysteroscopically (Esp type 0 and type 1)</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page 376, DC Duttas&rsquo;s Textbook of Gynecology 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 76037,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19045,
      "choices": [
        {
          "id": 76140,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Copper intrauterine device</span></span></span></p>"
        },
        {
          "id": 76141,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Combination oral contraceptives (COCs)</span></span></span></p>"
        },
        {
          "id": 76142,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nonsteroidal anti-inflammatory drugs (NSAIDS) </span></span></span></p>"
        },
        {
          "id": 76143,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Levonorgestrel-releasing intrauterine system (LNG-IUS)</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All EXCEPT which of the following are appropriate medical treatments for adenomyosis?</span></span></p>",
      "unique_key": "Q9382442",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745755,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Copper intrauterine device</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adenomyosis can be managed medically</span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">NSAIDs</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anti-fibrinolytics</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Combined OCPS</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">LNG-IUS</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SPRMs </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Surgical (Hysterectomy) is the definitive treatment of adenomyosis</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A copper containing IUCD will increase the bleeding and should not be used for adenomyosis</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 76140,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19048,
      "choices": [
        {
          "id": 76152,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Myometrial cells</span></span></span></p>"
        },
        {
          "id": 76153,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ectocervical cells</span></span></span></p>"
        },
        {
          "id": 76154,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endometrial glands and stroma</span></span></span></p>"
        },
        {
          "id": 76155,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endocervical glands and stroma</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">With endometriosis, as shown here, which of the following is ectopically located?</span></span></p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/7.jpg\" style=\"height:491px; width:643px\" /></span></span></p>",
      "unique_key": "Q2252505",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745756,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Endometrial glands and stroma</span></strong></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endometriosis is the presence of endometrial tissue (including glands and stroma) outside the uterus. </span></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:&nbsp;</span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endometriosis is the presence of endometrial tissue (including glands and stroma) outside the uterus.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The most common site is the ovary where it presents as an endometriotic cyst (Chocolate cyst)</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page 253, DC Dutta Textbook of Gynecology 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 76154,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19049,
      "choices": [
        {
          "id": 76156,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lymphatic spread</span></span></span></p>"
        },
        {
          "id": 76157,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hormonal induction</span></span></span></p>"
        },
        {
          "id": 76158,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Coelomic metaplasia</span></span></span></p>"
        },
        {
          "id": 76159,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Retrograde menstruation</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following theories is the most widely accepted as the cause of endometriosis?</span></span></p>",
      "unique_key": "Q6288174",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745757,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Retrograde menstruation</span></strong></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></strong></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The definitive cause of endometriosis remains unknown, but theories have been proposed.</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Retrograde menstruation through the fallopian tubes: Most favored theory </span></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">All the other options are less favoured theories. These include:</span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The stem cell theory: implicates undifferentiated endometrial cells that initially reside in the endometrium&rsquo;s basalis layer. These cells differentiate into epithelial, stromal, and vascular cells as the endometrium is routinely regenerated each cycle. If displaced to an ectopic location, such as by retrograde menstruation, these stem cells may give rise to endometriosis </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Aberrant lymphatic or vascular spread of endometrial tissue has also been implicated. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Coelomic metaplasia and suggests that the parietal peritoneum is pluripotent and can undergo metaplastic transformation to tissue histologically identical to normal endometrium. </span></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:&nbsp;</span></span></span></strong></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The most common theory of endometriosis is the theory of retrograde menstruation</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 231, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 76159,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19060,
      "choices": [
        {
          "id": 76200,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Danazol</span></span></span></p>"
        },
        {
          "id": 76201,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Aromatase inhibitors</span></span></span></p>"
        },
        {
          "id": 76202,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Laparoscopic ablation of lesions</span></span></span></p>"
        },
        {
          "id": 76203,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gonadotropin-releasing hormone (GnRH) agonists</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Women seeking immediate fertility and who suffer from endometriosis would most likely benefit from which of the following treatments?</span></span></span></p>",
      "unique_key": "Q8430512",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745758,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Laparoscopic ablation of lesions</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment of endometriosis is by both medical or surgical management</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">If pain is prominent and conception is not currently desired, then medical therapy is typically selected. </span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Available agents include NSAIDs, OCPs, progestins, GnRH agents, and aromatase inhibitors. </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In general, suitable starting regimens are NSAIDS alone or combined with oral contraceptive pills or with a progestin. </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Although medical treatment improves pain, relapse rates are high with therapy discontinuation.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">If infertility is the presenting symptom, then laparoscopic management should be considered (ablation/ excision of endometriotic implants)</span></span></span></li>\r\n</ul>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/22.jpg\" style=\"height:1345px; width:1921px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page 265, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 76202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19061,
      "choices": [
        {
          "id": 76204,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Drainage</span></span></span></p>"
        },
        {
          "id": 76205,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cystectomy</span></span></span></p>"
        },
        {
          "id": 76206,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cyst wall ablation</span></span></span></p>"
        },
        {
          "id": 76207,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">None of the above</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For surgical treatment of endometriomas, which of the following approaches is superior?</span></span></span></p>",
      "unique_key": "Q7147959",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745759,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Cystectomy</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endometriomas are typically treated surgically to exclude malignancy or treat associated pain. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cystectomy lowers endometrioma recurrence rates and pain symptoms and improves subsequent spontaneous pregnancy rates </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">During surgery, ideally normal ovarian tissue is preserved as much as possible</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 269, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 76205,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19062,
      "choices": [
        {
          "id": 76208,
          "text": "<p><span style=\"font-size:12.0pt;\">Ablation of the lesions</span></p>"
        },
        {
          "id": 76209,
          "text": "<p><span style=\"font-size:12.0pt;\">Ovarian cystectomy</span></p>"
        },
        {
          "id": 76210,
          "text": "<p><span style=\"font-size:12.0pt;\">Laparoscopic ovarian drilling</span></p>"
        },
        {
          "id": 76211,
          "text": "<p><span style=\"font-size:12.0pt;\">Laparoscopic adhesiolysis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year woman is undergoing a diagnostic laparoscopy for unexplained infertility. The following is seen. What is the best management option?</span></p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/10.jpg\" alt=\"\" width=\"400\" height=\"295\"></span></p>",
      "unique_key": "Q7046807",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745760,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Ablation of the lesions</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Explanation</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The black-brown lesions seen on the surface of the ovary are endometriotic lesions</span></li><li><span style=\"font-size:12.0pt;\">Endometriotic lesions like these require to be ablated so that the ectopic endometrium is destroyed</span></li><li><span style=\"font-size:12.0pt;\">Ovarian tissue should not be damaged</span></li></ul><p>&nbsp;</p><p><strong>Other Options:</strong></p><p><strong>&nbsp;</strong></p><p><strong>Option B. Ovarian cystectomy:</strong> Done for endometrioma, not for surface lesions. there are no endometrioma to be removed in this case</p><p>&nbsp;</p><p><strong>Option C. Laparoscopic ovarian drilling:</strong> It is not a treatment for endometriosis. It is used for infertility management in PCOS</p><p>&nbsp;</p><p><strong>Option D. Laparoscopic adhesiolysis:</strong> There are no adhesions in the image. no requirement of adhesiolysis.</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 264, Williams Gynecology 3<sup>rd</sup> edition</strong></span></p>",
      "correct_choice_id": 76208,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19102,
      "choices": [
        {
          "id": 76368,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anti-fibrinolytics</span></span></span></p>"
        },
        {
          "id": 76369,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hysterectomy</span></span></span></p>"
        },
        {
          "id": 76370,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Trans-cervical resection of the endometrium</span></span></span></p>"
        },
        {
          "id": 76371,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endometrial biopsy</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 52y woman who has been menopausal for more than a year presents to the OPD with complains of bleeding since 3 days. She thinks it may be a part of menopause but is a little concerned as she used to have heavy bleeding during her periods several years earlier. She is on anti-hypertensives. On examination, her vitals are stable. Abdominal exam is unremarkable. A speculum exam shows a normal cervix with blood visible at the os. The uterus is normal in size. A transvaginal scan shows an endometrial thickness of 8mm with b/l normal ovaries. What is the next best step?</span></span></p>",
      "unique_key": "Q4315684",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745761,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: D. Endometrial biopsy</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is a woman who is having post-menopausal bleeding (PMB)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The most common causes of PMB is endometrial atrophy but also it is important to rule out malignancies in this age group</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">As the cervix appears normal and the TVS shows an increased endometrial thickness (it should be &lt; 5mm in the post-menopausal age group), the next best step would be to take an endometrial biopsy. This can be done by</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Office biopsy (Endometrial aspiration)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dilatation and curettage</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hysteroscopic guided biopsy (gold standard)</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><em><strong>Other Options</strong></em></p>\r\n\r\n<ul>\r\n\t<li><em><strong>Option A: Antifibrinolytics:&nbsp;</strong><span style=\"font-size:14px\">This is indicated in women with heavy menstrual bleeding. However in post menopausal bleeding, the main aim is to rule out a malignancy</span></em></li>\r\n\t<li><em><strong>Option B: Hysterectomy:&nbsp;</strong>This won&#39;t be the initial step. The initial step is to diagnose the cause of post menopsuasal bleeding</em></li>\r\n\t<li><em><strong>Option C:&nbsp;</strong></em><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Trans-cervical resection of the endometrium: </span></span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is a type of endometrial ablation and is recommended in heavy menstrual bleeding. It is however c/i in premalignant and malignant lesions and those need to be ruled out by an endometrial biopsy</span></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:&nbsp;</span></span></span></strong></p>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/image.png\" style=\"height:569px; width:819px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page 376, DC Duttas&rsquo;s Textbook of Gynecology 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 76371,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19116,
      "choices": [
        {
          "id": 76424,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Polymenorrhoea</span></span></span></p>"
        },
        {
          "id": 76425,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Oligomenorrhoea</span></span></span></p>"
        },
        {
          "id": 76426,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Metrorrhagia</span></span></span></p>"
        },
        {
          "id": 76427,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Menorrhagia</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 34y woman presents with abnormal uterine bleeding to the OPD. She had a copper containing intra-uterine device inserted a few months earlier after which she has been having this problem. What is the kind of AUB she would be having?</span></span></p>",
      "unique_key": "Q2249437",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745762,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: D. Menorrhagia</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Intra uterine copper device typically causes menorrhagia due to acute inflammatory reaction in the endoemtrium&nbsp;</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This usually settles down aftera few cycles</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Educational Objective:</strong></em></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Causes of menorrhagia</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">IUCD</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fibroid</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adenomyosis</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endometrial hyperplasia</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endometrial polyps</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page 376, DC Duttas&rsquo;s Textbook of Gynecology 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 76427,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19117,
      "choices": [
        {
          "id": 76428,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Hysterectomy</span></span></span></span></p>"
        },
        {
          "id": 76429,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Endometrial ablation</span></span></span></span></p>"
        },
        {
          "id": 76430,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Insertion of LNG-IUS</span></span></span></span></p>"
        },
        {
          "id": 76431,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Combined oral contraceptives</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 47-year-old P3 presents with heavy bleeding following periods of amenorrhoea. She has been experiencing this symptom on and off since several months now and attributed it to nearing menopause. On examination, her BMI is 30. Vital signs are normal. Abdominal examination is normal and a bimanual pelvic exam reveals a normal sized uterus. An ultrasound shows a thickened endometrium for which she undergoes an office biopsy. This shows endometrial hyperplasia without atypia. The best treatment option for her is:&nbsp;</span></span></span></p>",
      "unique_key": "Q1368794",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745763,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans: C.</span></span> </strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Insertion of LNG-IUS</span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The LNG-IUS (Mirena) is the first-line medical treatment&nbsp;of simple endometrial hyperplasia (without atypia)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Continuous progestogens can also be be used (medroxyprogesterone 10&ndash;20 mg/day or norethisterone 10&ndash;15 mg/day) for women who decline the LNG-IUS.&nbsp;</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Treatment should be for a minimum of 6 months in order to induce histological regression of </span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">endometrial hyperplasia without atypia.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Endometrial surveillance - at a minimum of 6-monthly intervals.&nbsp;</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">In the presence of atypia, hysterectomy with b/l salpingo-oophorectomy should be done. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Other Options:</span></span></span></span></strong></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>Option A:</strong> Hysterectomy: This is not indicated in the absence of atypia as the risk of malignany is low</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>Option B:</strong> Endometrial ablation: This is not indicated in endometrial ablation</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>Option D: </strong>Combined OCPs: This is not preferred in endometrial hyperplasia. High dose proegesterone is preferred</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><em><strong>Educational Objective:</strong></em></span></span></p>\r\n\r\n<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/image_4rYZFj0.png\" style=\"height:554px; width:852px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: Green-top Guideline No. 67 RCOG/BSGE Joint Guideline | February 2016&nbsp;&nbsp;</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><a href=\"https://www.rcog.org.uk/globalassets/documents/guidelines/green-top\" style=\"color:#0563c1; text-decoration:underline\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">https://www.rcog.org.uk/globalassets/documents/guidelines/green-top</span></span></a></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> guidelines/gtg_67_endometrial_hyperplasia.pdf</span></span></strong></span></span></p>",
      "correct_choice_id": 76430,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18435,
      "choices": [
        {
          "id": 73698,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Breastfeeding &lt; 6 weeks postpartum </span></span></span></p>"
        },
        {
          "id": 73699,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Uncontrolled Hypertension with BP 150/90 mmHg</span></span></span></p>"
        },
        {
          "id": 73700,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">History of Cerebrovascular disease</span></span></span></p>"
        },
        {
          "id": 73701,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">History of Pulmonary embolism</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">All the following fall under Medical Eligibility Criteria 4 of Combined oral contraceptives except?</span></span></span></p>",
      "unique_key": "Q2614412",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745764,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: B. Uncontrolled Hypertension with BP 150/ 90 mmHg</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The WHO has defined Medical Eligibility Criteria for using contraceptives. These are</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/02/screenshot-2024-01-02-124732.jpg\" style=\"height:294px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MEC Category 4 for Combined Oral Contraceptives include:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Breastfeeding and &lt; 6 weeks postpartum</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Not breastfeeding; &lt; 21 days postpartum with risk factors for Venous Thromboembolism</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Age &ge; 35 years with smoking &ge; 15 cigarettes/ day</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypertension with systolic BP &ge; 160 OR Diastolic BP &ge; 100 mmHg</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypertension with vascular disease</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">History of DVT/Pulmonary embolism</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;Acute DVT/ Pulmonary embolism</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">DVT/ Pul embolism on anticoagulant therapy</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Major surgery with prolonged immobilization</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Known thrombogenic mutations (e.g. Factor V Leiden, prothrombin mutation, protein S, C, antithrombin deficiency)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Current and history of ischaemic heart disease</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Stroke (history of Cerebrovascular disease)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Complicated valvular heart disease</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Antiphospholipid Antibody Syndrome</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Migraine with aura (any age)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Current breast cancer</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Severe cirrhosis</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hepatocellular ademona/ carcinoma</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">**Family h/o DVT/ Pul embolism falls under category 3 and not category 4</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">&nbsp;Let&#39;s review each option in this context:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A.</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Breastfeeding &lt; 6 weeks postpartum</span></strong>: This falls under Category 4 for combined oral contraceptives (COCs). Estrogen in COCs can reduce milk supply and potentially affect breast milk production . Therefore, their use is generally not recommended for women who are less than 6 weeks postpartum and are breastfeeding.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B.</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uncontrolled Hypertension with BP 150/90 mmHg</span></strong> (Correct Answer): This condition actually falls under Category 3 for COCs, which means that the risks usually outweigh the benefits, but COCs may be used in some circumstances if no better alternatives are available. Controlled hypertension, however, would be a different scenario with different categorization.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">History of Cerebrovascular Disease</span></strong>: Women with a history of cerebrovascular disease are categorized under MEC 4 for COCs due to the increased risk of thrombotic events associated with estrogen. The use of COCs could significantly elevate the risk of stroke in these women.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">History of Pulmonary Embolism</span></strong>: A personal history of thrombotic events is MEC category 4 . A family history of pulmonary embolism, particularly in first-degree relatives, may indicate a genetic predisposition to thrombotic events but this alone does not typically fall under Category 4 for COCs unless the individual has other risk factors or a personal history of thrombotic events. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">In the context of contraceptive eligibility, certain conditions like breastfeeding less than 6 weeks postpartum and a history of cerebrovascular disease are contraindications (Category 4) for the use of combined oral contraceptives due to the increased risks associated with estrogen. However, uncontrolled hypertension with BP 150/90 mmHg falls under Category 3, where the risks usually outweigh the benefits but may be considered if no better alternatives exist.</span></span> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref : WHO </span></span></strong>&nbsp;<span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><a href=\"https://www.who.int/publications-detail-redirect/9789241549158\" style=\"color: blue;\"><strong><span style=\"font-size:12.0pt\">Medical eligibility criteria for contraceptive use</span></strong></a></span></span><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">&nbsp;(Fifth </span></span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#1a1a1a\">edition, 2015)</span></span></span></strong></p>",
      "correct_choice_id": 73699,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18324,
      "choices": [
        {
          "id": 73254,
          "text": "<p><span style=\"font-size:12.0pt;\">Does not need any additional contraceptive</span></p>"
        },
        {
          "id": 73255,
          "text": "<p><span style=\"font-size:12.0pt;\">Needs additional contraception for 3 months</span></p>"
        },
        {
          "id": 73256,
          "text": "<p><span style=\"font-size:12.0pt;\">Needs additional contraception till a semen analysis shows azoospermia</span></p>"
        },
        {
          "id": 73257,
          "text": "<p><span style=\"font-size:12.0pt;\">Needs additional contraception till 1 month</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 34y man undergoes a no scalpel vasectomy. What is the post operative advise?</span></p>",
      "unique_key": "Q5503292",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745765,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C.</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>Needs additional contraception till a semen analysis shows azoospermia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">After vasectomy, clients can resume sexual activity as soon as it is comfortable for them.</span></li><li><span style=\"font-size:12.0pt;\">This usually takes at least two to three days after the procedure.</span></li><li><span style=\"font-size:12.0pt;\">Counsel clients that vasectomy does not work immediately, and they can still get their partners pregnant.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Post vasectomy clients have to use condoms or their partners should use another family planning method consistently and correctly for at least three months.</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>After three months, client should return to the clinic for a semen analysis to make sure that the vasectomy was successful.</strong></span></li><li><span style=\"font-size:12.0pt;\">All vasectomy clients should be provided with instructions and practice on the correct use of condoms for use immediately after the vasectomy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">After vasectomy, clients can resume sexual activity as soon as it is comfortable for them.</span></li><li><span style=\"font-size:12.0pt;\">This usually takes at least two to three days after the procedure.</span></li><li><span style=\"font-size:12.0pt;\">Patients should be counseled that vasectomy does not work immediately, and they can still get their partners pregnant.</span></li><li><span style=\"font-size:12.0pt;\">Post vasectomy clients have to use condoms or their partners should use another family planning method consistently and correctly for at least three months.</span></li><li><span style=\"font-size:12.0pt;\">After three months, client should return to the clinic for a semen analysis to make sure that the vasectomy was successful.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: </strong></span><a href=\"https://nhm.gov.in/images/pdf/programmes/family-planing/guidelines/Reference_Manual_for_Male_Sterilization-NSV-Oct_2013.pdf\"><span style=\"font-size:12.0pt;\"><strong><u>https://nhm.gov.in/images/pdf/programmes/family-planing/guidelines/Reference_Manual_for_Male_Sterilization-NSV-Oct_2013.pdf</u></strong></span></a></p>",
      "correct_choice_id": 73256,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18318,
      "choices": [
        {
          "id": 73230,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Mifepristone + Misoprostol</span></span></span></span></p>"
        },
        {
          "id": 73231,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Vacuum aspiration</span></span></span></span></p>"
        },
        {
          "id": 73232,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Extra-amniotic instillation of ethacridine</span></span></span></span></p>"
        },
        {
          "id": 73233,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Concentrated oxytocin</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The preferred method for an induced abortion at 10 weeks is:</span></span></span></p>",
      "unique_key": "Q7967505",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745766,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans: B. Vacuum aspiration</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Explanation</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/10/untitled-661.jpg\" style=\"height:171px; width:900px\" /></span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:14px\"><strong>Other Options:&nbsp;</strong></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14px\"><strong>Option A: </strong>Mifepritone + Misoprostol is preferred till 9 weeks but efficacy reduces after 7 weeks</span></li>\r\n\t<li><span style=\"font-size:14px\"><strong>Option C: </strong>Extra amniotic instillation of ethacridine lactate: This is done very rarely now in 2nd trimester abortions</span></li>\r\n\t<li><span style=\"font-size:14px\"><strong>Option D: </strong>Concentrated oxytocin: This is a rare approach, sometimes tried for 2nd trimester abortions</span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><em><strong>Educational Objective:&nbsp;</strong></em></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/10/untitled-661.jpg\" style=\"height:171px; width:900px\" /></span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 164, DC Dutta&rsquo;s Textbook of Obstetrics 9<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 73231,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 30877,
      "choices": [
        {
          "id": 123386,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Perform a pap smear </span></span></span></p>"
        },
        {
          "id": 123387,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Perform a cervical biopsy </span></span></span></p>"
        },
        {
          "id": 123388,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Refer to a gynecologic oncologist </span></span></span></p>"
        },
        {
          "id": 123389,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Obtain a computed tomography (CT) scan</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman comes in for an annual gynecologic examination. During speculum examination, you see the following. What is the most appropriate next step?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/18/picture118_GSGLEOW.jpg\" style=\"height:274px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q9661827",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745767,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans: B. Perform a cervical biopsy.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">When a lesion is seen on the cervix, a biopsy should always be taken using a punch biopsy forceps</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In this image, a lesion is seen, so a biopsy should be taken from the periphery of the lesion</span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A pap smear is done when there is no visible lesion on the cervix</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Imaging studies and referral to a gyn oncologist have a role in cervical cancer once a diagnosis is made</span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">When a lesion is seen on the cervix, a biopsy should always be taken using a punch biopsy forceps</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In this image, a lesion is seen, so a biopsy should be taken from the periphery of the lesion</span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 663, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 123387,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19338,
      "choices": [
        {
          "id": 77312,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laparoscopic hysterectomy with preservation of ovaries </span></span></span></p>"
        },
        {
          "id": 77313,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laparoscopic hysterectomy with transposition of ovaries</span></span></span></p>"
        },
        {
          "id": 77314,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Radical trachelectomy </span></span></span></p>"
        },
        {
          "id": 77315,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Simple trachelectomy</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mrs Rina, a 35 year old P1L1 has 1.5 x 1.5cm growth limited to the cervix. A biopsy reveals squamous cell carcinomal of the cervix and an MRI reveals no other involvement of surrounding structures. She wishes to undergo fertility preserving surgery and future childbearing . Which of the following would be an appropriate management for her: </span></span></p>",
      "unique_key": "Q4857793",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745768,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. C. Radical trachelectomy. </span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Radical trachelectomy is a procedure that is gaining popularity as a surgical management option for women with stage 1A2 and IB1 disease who desire uterine preservation and fertility. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">As this patient would fall into Stage 1 A2, this treatment modality can be offered</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">It is Suitable for tumors less than 2cm size.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">In radical trachelectomy, the following is removed</span></span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The cervix</span></span></span></span></li>\r\n\t\t<li>Part of parametria and paracolpos</li>\r\n\t\t<li>Part of uterosacral ligaments</li>\r\n\t\t<li>1-2 cm of vaginal cuff</li>\r\n\t\t<li>Descending cervico-vaginal branch of uterine artery is ligated</li>\r\n\t\t<li>Permamant encerclage of the cervical stump&nbsp;</li>\r\n\t\t<li>Pelvic lymoh nodes</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>Other Options:&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><strong>Option A:&nbsp;<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laparoscopic hysterectomy with preservation of ovaries:&nbsp;</span></span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">This can also be considered in a woman wanting to preserve fertility but she will require a gestational surrogate</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option B:</strong>&nbsp;Laparoscopic hysterectomy with transposition of ovaries: Transposition of the ovaris is usually done if the woman is to recieve pelvic radiotherapy</span></span></span></li>\r\n\t<li><strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Simple trachelectomy is not an option in early stage cervical cancer.&nbsp;</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:14px\"><strong><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educatiional Objective:&nbsp;</span></span></strong></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Radical trachelectomy is a procedure that is gaining popularity as a surgical management option for women with stage 1A2 and IB1 disease who desire uterine preservation and fertility.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref: berek and novak, 16<sup>th</sup> edition page 2473</span></span></strong></span></span></p>",
      "correct_choice_id": 77314,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}